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Preface
The National Institute on Drug Abuse (NIDA) is concerned about the
acquired immunodeficiency syndrome (AIDS) for two reasons. First,
intravenous drug abusers constitute approximately 25 percent of
reported AIDS patients in the United States. Human immuno-
deficiency virus (HIV) infection is transmitted among intravenous drug
abusers primarily when contaminated needles and other paraphernalia
used to inject drugs are shared. Infected drug abusers are capable of
transmitting HIV to their sexual partners during sexual contact and
to their unborn children during pregnancy. Second, the use of drugs
may expedite disease progression by further decreasing immune
function or by acting as the vehicle of transmission of other infec-
tious agents, such as hepatitis B virus, which may also be immuno-
suppressive. Drugs of abuse may promote the development of
malignancies. Nitrite inhalants, commonly used by homosexual men,
have been associated with Kaposi’s sarcoma (KS) in AIDS. The
mechanism of action of nitrites as a cofactor in KS, if any, has yet
to be elucidated.
On March 31, 1987, NIDA sponsored a technical review entitled “The
Extent of Use and Health Hazards of Nitrite Inhalants.“ Approxi-
mately 25 scientists attended the meeting in Rockville, MD. The
purpose of the workshop was to review the status of research
regarding nitrite inhalants and their potential public health implica-
tions and to set directions for future studies. In part, this meeting
was called to provide up-to-date information about nitrite inhalants
for NIDA to respond to a congressional request for information as
part of the Anti-Drug Abuse Act of 1986.
This monograph is a collection of presentations delivered at the
meeting. The chapters are organized to present the history of nitrite
use; the basic biochemical, pharmacologic, and toxicologic effects of
various forms of alkyl nitrites; the effects of nitrite use on the
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immune system; and epidemiological findings associating nitrite use
with KS in AIDS. The purpose of this introduction is to provide an
overview of issues and controversies raised at the meeting that are
covered in more detail in individual chapters.
There are many controversial issues surrounding nitrites, not the
least of which are their current regulatory status. As Guy Newell
discusses in his historical presentation, amyl nitrite is a prescription
drug, but butyl nitrite, with effects very similar if not identical to
the amyl congener, is not considered to be a drug because it is
marketed as a “room odorizer.” Proposals to regulate the sale of
butyl nitrites have been periodically considered by various agencies of
the Federal Government.
A series of metabolic and toxicity studies of four nitrite butyl esters
in mice was presented by Roger Maickel. The lethality of these
compounds was related to rapid hydrolysis to nitrite ions with the
subsequent oxidation of hemoglobin to methemoglobin. However,
methemoglobin formation cannot account for all toxic effects. While
there were wide differences in toxicity, the relative toxic potencies
of the four butyl nitrite isomers found in “room odorizers" were
maintained under a variety of experimental conditions and routes of
administration.
The acute toxicity of nitrites in animals and man was reviewed by
Ronald Wood. Skin and tracheobronchial irritations (especially about
the nose and lips), burns from accidental ignition, headaches,
hypotension, cyanosis, methemoglobinemia, intoxication, and the
development of habitual use patterns are possible adverse effects of
nitrite inhalation.
Much of the discussion at the meeting focused on two possible
pharmacologic mechanisms by which nitrites may be involved in the
genesis of KS in AIDS: carcinogenicity and immunosuppression.
Although dependent on an unproven and controversial mechanism,
nitrites have been hypothesized to interact with organic amines and
amides in vivo to form significant amounts of highly carcinogenic
N-nitrosamines. Direct data on the carcinogenicity of nitrites in
animals are sparse. However, the in vitro studies of lipid peroxida-
tion and the finding of route-dependent in vivo formation of
nitrosamines from amyl nitrite and methylaniline in mice, reported by
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Sidney Mirvish, suggest that the possibility warrants serious
investigation. Interestingly, the areas where absorbed concentrations
of volatile nitrites would be expected to be highest--the skin
surrounding the nose and in the nasal/pulmonary mucosa-are also
reported to be the areas in which KS occurs in persons with AIDS.
This association logically leads to the hypothesis that there is a
causal relationship between nitrites and KS, perhaps mediated by the
formation of N-nitroso compounds. How HIV infection initiates or
promotes this process is not clear.
Besides participating in the formation of carcinogenic metabolites,
alkyl nitrites may increase the likelihood of KS by altering immune
function. Dan Lewis, Jesse Ortiz, and Elizabeth Dax studied the
effects of nitrites on immunologic function using variations on two
basic strategies: first, examination of effects on immunologic
components (lymphocyte numbers, thymus weight, etc.) and second,
measurement of effects of nitrite pretreatment on the responsiveness
of immune system components to challenge with various adjuvants,
mitogens, and antigens. Given the complexity of the immune systems
in mice and humans, the possible variations in nitrite exposure
parameters, the large number of dependent variables and sampling
times to choose from, and the diversity of analytic methods available,
one might have predicted in advance the divergent results obtained.
Lewis reported no significant detrimental effects on the immune
systems of mice from exposures to 300 parts per million isobutyl
nitrite vapor for 13 weeks. However, the other two researchers
showed different patterns of decreases in T-lymphocyte numbers and
changes in immune functions after 21 weeks of intranasal amyl nitrite
in mice (Ortiz, this volume) or after 13 sessions of amyl nitrite
inhalation in human volunteers (Dax, this volume). lt is apparent
that there is much to learn before the relevance of nitrites to
disease processes, such as KS, is understood.
Much has been written about the extent of nitrite use among
homosexual men. In addition, household and high school surveys have
quantitated use of nitrites among adolescents and young adults, but
these surveys have not distinguished use by sexual orientation. In
this monograph two surveys of nitrite inhalant use by drug abusers
are presented. Richard Schwartz presents data collected from
adolescents at a residential drug treatment community in suburban
Virginia. Schwartz also assesses the rates of acute toxicity attrib-
uted to nitrites among adolescent abusers. Robert Lange presents
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data concerning nitrite use among intravenous drug abusers in
treatment from six regions of the United States and among homo-
sexual men in Baltimore. Lange suggests that nitrite use is decreas-
ing among homosexual men because of the fear of an association with
AIDS. Nitrite use among intravenous drug abusers is not as extensive
as among homosexual men and is not apparently changing.
The unique epidemiology of KS in AIDS suggests that a cofactor is
necessary to explain its pathogenesis. Harry Haverkos reviewed the
existing epidemiologic studies of nitrite use and KS in homosexual
men and found inconclusive results; nitrite use is associated with KS
in some studies but not in others. In discussing the variables that
may be responsible for the varied results, he ruled out bloodborne
infectious agents and focused attention on drug use and sexually
transmitted microbial agents as the most likely places to look for the
KS cofactor. His discussion points out the difficulties of interpreting
questionnaire data when sample sizes are small and methods,
populations, and questions vary. Tighter control over survey
conditions and standardized methods would make these studies more
efficient, but may be impractical to achieve.
An open discussion moderated by Dr. Newell followed the presen-
tations at the workshop. More epidemiologic and laboratory studies
are needed to assess the role, if any, of nitrite inhalants as a
cofactor in AIDS-related KS. There is a need to develop question-
naires for studies that access nitrite exposure over one’s lifetime,
analogous to pack-years in cigarette usage. Despite the epidemiologic
associations with KS, butyl nitrite has never been tested as a car-
cinogen. Such studies should be conducted. Studies of animal
models infected with retroviruses and challenged with large quantities
of nitrites before, during, and/or after retrovirus infection would be
useful.
More research is needed to determine the dose-response curve of
nitrite inhalation in humans. Many individuals use other drugs, such
as alcohol, marijuana, and/or cocaine, with nitrites. What are the
effects of these drugs in combination?
Nitrite inhalants are important drugs of abuse in the United States.
Their association with KS and AIDS raises an important scientific
question about possible synergistic reactions between viruses and
chemicals in the development of cancer. It is our hope that this
x
monograph will stimulate interest in nitrite inhalant research and
attract investigators who can conduct the multidisciplinary research
necessary to address the scientific questions raised at this NIDA
technical review.
Harry W. Haverkos, M.D.
Clinical Medicine Branch
Division of Clinical Research
National Institute on Drug Abuse
Rockville, MD
John A. Dougherty, Ph.D.
Veterans Administration Medical Center
Lexington, KY
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Nitrite Inhalants: Historical
Perspective
Guy R. Newell, Margaret R. Spitz and
Michael B. Wilson
INTRODUCTION
Early studies of Kaposi’s sarcoma (KS), manifesting as part of the
acquired immune deficiency syndrome (AIDS), showed that many
people with KS had used volatile nitrites. In the body, nitrites may
be converted to N-nitroso compounds, which are known to be
mutagens, teratogens, and strong carcinogens. In addition, studies
found nitrites to have potent immunosuppressive properties. These
facts led us to consider volatile nitrites as possible etiologic
cofactors in AIDS-related KS.
THERAPEUTIC USE OF NITRITES
In 1859, the vasodilatory effect that follows inhalation of amyl nitrite
was described. This led to its first therapeutic use in 1867 as relief
from angina pectoris (Brunton 1867). The original form of the drug
was glass ampules enclosed in mesh: they were called pearls. When
crushed between the fingers, they made a popping sound; hence, the
colloquialism “poppers” evolved. Butyl nitrite was also investigated in
the late 1880s. Although it has the same properties as amyl nitrite,
it was never used clinically (Brunton 1897). lsobutyl nitrite is a
third member of this family of compounds, and the vasodilatory
effects of these three aliphatic nitrites-amyl, butyl, and isobutyl-
were found to be similar (Haley 1980). Nitrites exert their vasodila-
tory effects by relaxing the muscles in blood vessel walls (Nickerson
1975). Vasodilation of the cerebral blood vessels causes an increase
in intracranial pressure, producing a euphoric effect or “high.” These
aliphatic nitrites were also reported to enhance sexual performance
(Everett 1975; Hollister 1975).
1
TOXICITY OF VOLATILE NlTRITES
In spite of having a wide range of human toxicities, amyl nitrite was
considered safe for therapeutic use (table 1). The Food and Drug
Administration (FDA) eliminated the prescription requirement in
September 1960. The pharmaceutical industry first presented
testimony regarding significant abuse of amyl nitrite among young
adults (Lubell 1964). Following that testimony in 1969, the FDA
reinstated the prescription requirement. However, abuse of this drug
continued in spite of the FDA’s regulation. The National Institute on
Drug Abuse noted 13 emergency room admissions resulting from
nitrite side effects in 1976, and it investigated 84 related complaints
that year (Reed 1979).
CARClNOGENIClTY OF N-NITROSO COMPOUNDS
Nitrite, present as a natural impurity in salt, was a key ingredient in
curing meats for thousands of years. Many foods are naturally rich
in nitrates, which are converted to nitrites by bacteria. Nitrite can
combine with other chemicals called amides or amines to form a
family of compounds called nitrosamines. These substances as a
group are among the most potent carcinogens known. Nitrosamines
are not permitted to be knowingly added to food at any level,
although it is likely that some foods contain small amounts of this
carcinogenic substance. In 1978, the FDA set the amount of
allowable nitrite to be added to bacon at 120 ppm and required that
bacon be free of preformed nitrosamines at 10 ppb, the lowest
amount detectable by available technology.
Magee and Barnes first reported the carcinogenicity of
N-nistrosodimethylamine (NDMA) in 1956 (Magee and Barnes 1956).
In all, 290 N-nitroso compounds have been tested for carcinogenicity,
and 252 (87 percent) of these have shown such activity (Bogovski and
Bogovski 1981). These compounds are active carcinogens in 39
different animal species; no species tested is resistant to their
carcinogenic effects (Preussmann 1983). Experiments on the
comparative metabolism of N-nitrosamines using animal and human
tissue provide convincing evidence of similar activating metabolic
pathways (Bogovski and Bogovski 1981). Thus, humans are most
likely to be susceptible to the carcinogenic effects of these
compounds. Organic nitrites, including amyl, butyl, and isobutyl
nitrite, are mutagenic according to the Ames test with or without
metabolic activation: N-nitroso compounds have the ability to induce
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TABLE 1. Toxicity of inhaled volatile nitrites
System or Illness Effects
Central Nervous System
Cardiovascular System
Hematologic System
Ocular Organs
Pulmonary Organs
Cancer
Light-headedness, weakness, nausea,
ataxia, delirium, headache (short-
lived “nitrite headaches” and pro-
longed pulsatile headaches), syncope
(after profound vasodilation), tol-
erance, sedation, and anesthesia.
(Last two effects reported for animals
exposed to high concentrations.)
Profound hypotension and cutaneous
flushing followed by reflex vasoconstric-
tion and tachycardia, and transient
electrocardiographic changes (inverted
T waves and depressed ST segments).
Methemoglobinemia (documented after
oral and parenteral administration and
repeatedly mentioned as a possibility
after inhalation; not reported in asso-
ciation with hedonistic use of these
substances), and normocytic normo-
chromic anemia after exposure in an industrial
setting.
Increased intraocular pressure and supra-
orbital pain.
Irritation (reported for animals exposed to
high concentrations).
Inhaled nitrites could interact freely with
endogenous trivalent nitrogen compounds
to produce nitrosamines that are known to
be carcinogens.
SOURCE: Adapted from Sigell et al. 1978, Copyright 1978, the American Psychiatric
Association.
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cancer after only one dose (Jorgensen 1982). These are among the
most potent known chemical carcinogens in animals.
lMMUNOSUPPRESSIVE EFFECTS OF VOLATILE NITRITES
In 1982, Goedert et al. found that the helper:suppressor ratio of
peripheral blood lymphocytes was lower among users of volatile
nitrite than among nonusers. This was the first indication that these
compounds had the potential to suppress the immune system in
humans. However, the possibility that poppers were only a surrogate
marker for other factors that were highly correlated with popper use
was not ruled out.
We demonstrated the immunosuppressive effects of nitrites on human
peripheral blood leukocytes in vitro (Hersh et al. 1983). Lymphocyte
blastogenesis, cell-mediated cytotoxicity, and monocyte adherence
were all Suppressed by concentrations of isobutyl nitrite that were
noncytotoxic in terms of cell viability. lsobutyl nitrite inhibited the
induction of a- and b-interferon, which also might contribute to
susceptibility to infectious diseases and manifestation of cancers in
users of these substances. These in vitro effects of isobutyl nitrite
were evident after only 2 hours of exposure of human lymphocytes in
culture, suggesting that prolonged exposure may not be necessary for
immunosuppressive and carcinogenic effects to occur. Cellular
cytotoxiclty was demonstrated (Jacobs et al. 1983) as was depression
of murine natural killer cells (Lotzova et al. 1984). We suggested
that continued use of these substances might interfere with attempts
to correct the immune system by other agents and, therefore, that
their use should be condemned.
NITRITES AS RECREATlONAL DRUGS
Butyl and isobutyl nitrites do not fit the definition of a food, drug,
or cosmetic as specified by the Federal Food, Drug, and Cosmetic Act
from which the FDA derives its regulatory authority. Therefore, they
are not subject to regulation by the FDA Because amyl nitrite was
no longer available after 1969 without a prescription, there was a
proliferation of different brands of butyl and isobutyl nitrite during
the early 1970s. Most commercial preparations contained some of
each type, along with unspecified impurities (Ostrow 1982; Hersh et
al. 1983).
In the 1970s. reports of nitrite use for augmentation of sexual
experiences along with descriptions of their aphrodisiac properties
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began (Louria 1970; Pearlman and Adams 1970; Everett 1972; Gay and
Sheppard 1972; Dimijian 1978; Hollister 1975). lsraelstam et al. (1978)
reported that amyl nitrite was known to have been used recrea-
tionally as early as the 1960s. They report on one man in San
Francisco who tried amyl nitrite in 1963. However, the popper craze
really only began during the years 1974 to 1977. By 1979, over 5
million people in the United States used these drugs more than once
a week (Mayer 1983).
Sigell et al, (1978) reported that the sale of nonprescription volatile
nitrites, commonly referred to as poppers, was a large business. An
estimated total of $50 million a year was made from the sales of
more than 100,000 bottles a week in just one city. Further, they
claimed that, prior to 1978, male homosexuals indulged in the use of
volatile nitrites more than any other group. A guide to homosexual
lovemaking asserts that the use of amyl nitrite has “passed into every
comer of gay life.” Nitrites were used primarily during sexual
activity because they reduce social and sexual inhibitions, heighten
sexual arousal, relax the anal sphincter, and are thought to prolong
orgasm (Lubell 1964, Sigell 1978; lsraelstam et al. 1978). The
chronology of volatile nitrite availability and use as it could relate to
AIDS-related KS was described (Newell et al. 1984; Newell et al.
1985b) and is given in table 2.
NITRITE USE REPORTED IN THREE CASE-CONTROL STUDlES
In December 1981, we began accepting referrals of individuals with
possible AIDS either with or without KS and opportunistic infections
(Ol). One hundred thirty-five lifestyle questionnaires were completed
by the first 145 referrals. At one extreme, 31 patients had either KS
or Ol as severe manifestations of AIDS; at the other extreme, 29
referrals were symptom-free and served as controls (Newell et al.
1985b). In spite of the small numbers in our study, we found a
statistically significant increased risk of 5.5 (95 percent confidence
interval 1.1-28.7) for KS/Ol patients who had used volatile nitrites
compared with symptom-free (SF) controls (Newell et al. 1985b). In
addition, there was a smooth dose-response gradient of 1.0 for those
who never used nitrites, 4.0 for those who occasionally used, and 6.3
for those who used them frequently (table 3). Predictably, there was
considerable confounding among several risk factors. In particular,
use of nitrites was confounded by such activities as marijuana use,
attending bathhouses, and active fisting (insertion of fist into the
rectum). The estimated risk of developing KS for each factor was
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TABLE 2. Chronology of volatile nitrite availability and use
Year Availability and Use
1859
1867
1880s
1960
1963
1960s
1969
1970
1974
1976
1977
1978
1979
1980
1981
Flushing of skin with amyl nitrite described
Therapeutic use of amyl nitrite for angina pectoris
Butyl nitrite investigated but not used clinically
Amyl nitrite prescription requirement eliminated by FDA
First report of recreational use
Recreational use common among young adults
Amyl nitrite prescription requirement reinstated by FDA
Street brands of butyl and isobutyl nitrite used;
JAMA reports use for sexual augmentation
Popper craze said to have begun
$50 million sales per year in one city
Nitrites permeate gay life
Three cases of KS/PCP found in retrospect
Over 5 million people used>once per week
19 cases of KS/PCP found in retrospect
56 cases of KS/PCP reported
Nitrite use suspected associated with KS/PCP
SOURCE: Adapted from Newell et al. 1985a, Copyright 1985, the American Journal of
Medicine.
high after taking the others into account. For example, stratification
of nitrite use by prior history of syphilis (table 4) resulted in odds
ratios of 1.0, 3.0, and 5.0 (never, occasional, and frequent use,
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respectively) among the 28 subjects with no prior history of syphilis
as well as among the 32 subjects with a prior history of syphilis.
This suggested that use of volatile nitrites was a significant risk
factor for developing KS, independent of a prior history of syphilis.
We also found that increasing use of nitrites paralleled sexual activity
(table 5).
Marmor et al. (1982) compared 20 KS patients with 40 homosexual
controls drawn from a physician’s practice and matched them for race
and age. The major predisposing risk factors for development of KS
among the patients were amyl nitrite use and number of sex partners
per month. Marmor found that development of KS was associated
with the use of amyl nitrite but not with the use of butyl nitrite.
We believe that butyl nitrite was the predominant form of nitrite
used, but amyl nitrite was endorsed because of the way the question
regarding nitrite use was phrased, as Marmor and associates
suggested. As noted above, the effects of amyl, butyl, and isobutyl
nitrites are the same (Haley 1980). One of Marmor’s patients
reported using nitrites only once, 3 years prior to diagnosis of his
KS.
The Centers for Disease Control (CDC) study (Jaffe et al. 1983)
compared 50 KS or Ol patients with 120 homosexual controls selected
from either a venereal disease clinic (78 controls), or a physician’s
practice (42 controls). In the CDC study, nitrite use was extensive
(95 to 96 percent) among patients and both control groups. However,
lifetime usage was significantly greater among patients than among
either of the control groups. In all three studies, controls were
drawn from physician practices or clinics, and so did not necessarily
represent the male homosexual population at large. However, since
the controls were probably in poorer health than individuals in the
ideal referent population would be, risk estimates would be biased in
favor of unity. Thus, any differences found would be minimum risk
estimates. This source of bias was discussed in each paper.
Comparable findings from the three studies are shown in table 6. In
all studies, use of nitrites by cases was more prevalent than use
among the controls. If one discards the one individual reported by
Marmor et al. (1982), who only used nitrites once, the percent of use
among the cases in the three studies is 95, 96, and 94 percent. In
any epidemic, it is not unusual for some patients not to give a clear
history of exposure. The comparable prevalence of exposure among
the control groups used by Jaffe et al. (1983) does not militate
against nitrites as a potential contributing factor for development of
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TABLE 3. Nitrite use as a risk factor for Kaposi’s sarcoma/
opportunistic infections (KS/Ol)
95 Percent
KS/Ol Controls Odds Conf id.
Nitrite Use Number Percent Number Percent Ratio Interval
Never 2 6.5 8 27.6 1.0 -
O c c a s i o n a l  7 22.5 7 24.1 4.0 0.6 - 26.0
Frequent 22 71.0 14 48.3 6.3 1.2 - 34.0
Overall Odds Ratio 5.5 1.1 - 28.7
NOTE: Never=once only or once per year to allow for the experimenter; occa-
sional=once per 6 months to once per month; frequent=once per month or
more.
SOURCE: Newell et al. 1985b, Copyright 1985. Oxford University Press.
TABLE 4. Nitrite use and history of syphilis
History of
Syphilis
Frequency of
Nitrite Use KS/Ol SF
Odds
Ratio
Never 1 6 1.0
No Occasional 2 4 3.0
Frequent 7 8 5.3
Never 1 2 1.0
Yes Occasional 5 3 3.3
Frequent 15 6 5.0
NOTE: Never=once only or once per year to allow for the experimenter: occas-
ional=once per 6 months to once per month: frequent=once per month or more
Often
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TABLE 5. Nitrite use by sexual activity
Nitrite Use
Average Number Average Number
Partners Different Partners
per Week per Week
Never 2.3 1.7
Occasional 3.1 2.0
Frequent 4.0 2.6
NOTE: Never=once only or once per year to allow for the experimenter;  occas-
ional=once per 6 months to once per month: frequent once per month or more
Often.
the disease. As noted above, the lifetime use was significantly
greater among cases than among both control groups. Also, Marmor
et al. (1982) noted that passive exposure at homosexual discotheques
was reported by many subjects. Laboratory studies showed that one
brief exposure to human lymphocytes in culture was sufficient to
cause immunologic damage (Hersh et al. 1983).
TABLE 6. Prevalence of nitrite use among three case-control
studies
Study
Cases
Number
Used Percent
Controls
Number
Used Percent
Marmor et al. 1982 20 100 40 68
Jaffe et al. 1983 50 96 120 96.95
Newell et al. 1985 31 94 29 72
COHORT EFFECT OF NlTRlTE EXPOSURE
Fifty percent of all patients in these studies with AIDS-related KS/Ol
were between 30 and 39 years of age, and 90 percent of all patients
were men between the ages of 20 and 49. The cohort of men 30 to
39 years old (mid-age 35) in 1980 would have been 20 to 29 years old
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(mid-age 25) in 1970 when volatile nitrites became available on the
open market. Further analyses of our data showed a dose-response
gradient among patients in the 30 to 39 age group, but not in the
other two age groups (table 7). The numbers of subjects in the
younger and older age groups were small.
TABLE 7. Odds ratios for nitrite use by age at referral
Nitrite Use
Age at Referral
20-29 30-39 40-49
Never 1.0 1.0 1.0
Occasional 6.0 4.0 1.0
Frequent 2.8 9.3 3.0
NOTE: Never=once only or once per year to allow for the experimenter; occas-
ional=once per 6 months to once per month: frequent=once per month or more
often.
Nevertheless, the increased risk clustered in the predicted age group.
This cohort would have reached mid-age of 30 years during 1975
when nitrite use was reported to be very common among male
homosexuals. The age of the cohort of men who were developing
KS/Ol is related to the history of nitrite availability and use shown
in table 8.
Four logical times for initial exposure to nitrites were: (1) 1965, the
central year from 1960 to 1969 during which amyl nitrite was
available without a prescription; (2) 1970, when street-variety nitrites
became available; (3) 1974, when the literature began reporting its
use among homosexual males; and (4) 1977, by which time its use was
repotted to be very common. Onset of the KS epidemic was reported
in mid-1981. We believe that 1965 is too soon for significant
exposure to have occurred, thus the lag time of 16 years is probably
too long. At the other extreme, the 4 years between 1977 and 1981
may be too short for the development of cancer, although it is
possible if the carcinogen were potent enough or the exposure were
highly concentrated. Metabolic products of inhaled nitrites may
satisfy both of these criteria. The bulk of the literature suggests
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that nitrite use had saturated the gay male population by 1974.
Thus, a better estimate for onset of exposure would be a peak in
1974 followed by the epidemic reported in 1981, a span of 7 years.
TABLE 8. Time intervals from exposure to nitrites to first report
of AIDS epidemic
Year
Availability and Use Onset of Epidemic
of Nitrites Reported 1981
1965 Amyl nitrite available
1960- 1969
16 years
1970 Street-variety
“poppers” available
11 years
1974 “Popper” craze
widely recognized
7 years
1977 Nitrites reported “in
every corner of gay life”
4 years
SUMMARY
There are important reasons for considering nitrite inhalation as a
factor in the development of AIDS-related KS in young male
homosexuals. These are (1) the pharmacologic properties of amyl,
butyl, and isobutyl nitrites, which are toxic; (2) the mutagenic,
teratogenic, and carcinogenic products resulting from metabolism of
N-nitroso compounds; (3) the potent carcinogenicity of N-nitroso
compounds in 39 different animal species: and (4) the deleterious
effects of volatile nitrites on human lymphocytes both in vitro and in
vivo .
Specifically related to this epidemic, there are additional reasons for
pursuing the connection between nitrite inhalation and development of
KS. These include: (1) the timing of the production and sales of
volatile nitrites for use as recreational drugs and the subsequent
outbreak of the AIDS epidemic (7 to 10 years); (2) the extensive use
of nitrites among male homosexuals; (3) the virtual universal history
of nitrite use by young male homosexuals in whom KS has developed
11
during the past 3 years; and (4) the age group in which KS is
developing is consistent with a cohort initially exposed 7 to 10 years
ago.
CONCLUSION
We conclude that nitrite use may contribute to the development of
AIDS-related KS among male homosexuals. lmmunosuppression may
allow expression of human immunodeficiency virus that was pre-
viously suppressed. The interaction of nitrites with other identified
risk factors is yet to be elucidated.
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The Fate and Toxicity of Butyl
Nitrites
Roger P. Maickel
INTRODUCTION
Volatile organic nitrites have evolved over the past quarter century
as popular street drugs, inhaled to after consciousness and intensify
sexual experiences (Sigell et al. 1978). Originally, the specific
compound used for this purpose was amyl nitrite, used in the
treatments of angina and poisoning by hydrogen sulfide or hydrogen
cyanide (Stine et al. 1978). This agent, which is primarily iso-pentyl
nitrite, was removed from the category of prescription drugs by the
Federal Drug Administration (FDA) in 1960; however, by 1968, abusive
use had become so common that it was returned to prescription
status (Israelstam et al. 1978).
Subsequently, the ready availability of butyl nitrites, used in a
variety of commercial applications (intermediates for perfumes,
antifreeze preparations, etc.), made these compounds an attractive
substitute. The pharmacology of the butyl nitrites is similar to that
of amyl nitrite; indeed, they were once considered as alternative
agents for the therapy of angina (Brunton 1897). They are presently
available from a variety of sources (pornography shops, “head” shops,
mail order catalogues) and can be obtained under a wide variety of
suggestive trade names (table 1). Nickerson et al. (1979) discussed
the pharmacology and uses of these compounds; a related report
discusses their abusive use and some biomedical effects (Pryor et al.
1980).
NATURE OF BUTYL NITRATES
The term “butyl nitrites” refers to four compounds, the nitrous acid
esters of n-butyl, isobutyl, sec-butyl, and tert-butyl alcohols. One of
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TABLE 1. Current trade names for butyl nitrites
Aroma of Men Heart On
Ban Apple Gas Highball
Bang Jac Aroma
Bolt Liquid Increase
Bullet Looker Room
Climax Mama Poppers
Crypt Tonight Oz
Cum RUSH
Discorama Satan’s Scent
Hardware Toilet Water
the problems in dealing with these substances is the fact that
commercially available samples are generally not pure. In fact,
analysis of such materials in this laboratory indicated that the labeled
component was actually from 44 to 96 percent of the sample (table
2). A sample of “RUSH,” sold as a “room odorizer” by Gemini Books,
Lafayette, IN, was found to be primarily isobutyl nitrite (IBN). The
compounds are rather unstable unless stored at low temperatures and
TABLE 2. GLC analysis of commercials available butyl nitrites
Compound Authentic Compound Maior Containment
Percent R.T.* R.T.*
(minutes)
Percent
(minutes)
lsobutyl nitrate (lBN)a 63 4.7 26 6.6
n-butyl nitrite (NBN)a 79 5.5 13 6.1
sec-butyi nitrite (SBN)a 44 4.0 56 5.6
tert-butyl nitrite (TBN)a 96 4.6 4 3.0
RUSHb 63 4.7 17 6.6
*Retention time.
aPfaltz and Bauer, Inc., Stamford, CT.
bPacific Western Distributing Corp.. San Frandsco, CA.
SOURCE: GLC analysis as reported by Maickel and McFadden (1979).
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in the absence of light, air, and water (Noyes 1943); the primary
breakdown products are the corresponding alcohols. When prepared
in the laboratory by the method of Noyes (1943), IBN, n-butyl nitrite
(NBN), and set-butyl nitrite (SBN) can be produced with >99 percent
purity: tert-butyl nitrite (TBN) requires a simple distillation process
to achieve a similar level of purity (Maickel and McFadden 1979).
STABILITY STUDIES
All butyl nitrites are believed to be rapidly hydrolyzed in vivo,
yielding the corresponding alcohols and nitrite ions (Sutton 1963).
Some idea of the rapidity of in vivo degradation of these compounds
may be observed in mice exposed to the butyl nitrites through
inhalation of concentrations sufficient to cause death within 10 to 20
minutes (i.e., 3,000, 2,000, 4,000, and 50,000 ppm of IBN, NBN, SBN,
and TBN, respectively). No detectable levels (less than 1 .0 ug/ml)
could be found of IBN, NBN, or SBN. Under these conditions, the
blood level of TBN was 16.7 ± 3.2 (SEM) u g/ml.
Since plasma levels of the butyl nitrites were so low even when mice
were exposed to lethal doses, it was felt that the stabilii of these
compounds should be assessed under various test conditions.
Accordingly, a study was performed of the stability of the various
butyl nitrites in 0.1 M phosphate buffer (pH=7.4) at 37 °C. The
results (table 3) showed that rapid decomposition of these compounds
occurred under such conditions. Three of the compounds (IBN, NBN,
and SBN) had monophasic decay curves with half-lives of 14.0, 15.2,
and 21.8 minutes, respectively, while TBN showed a blphasic decay
curve with a half-life of 5.6 minutes for the first phase, and 16.2
minutes for the second phase. All four compounds decayed according
to first order kinetics.
When similar studies were performed using mouse plasma (rather than
phosphate buffer) under similar conditions, even more rapid degrada-
tion was observed (table 4). All four compounds showed a rapid
initial decay phase (with a half-life of 2.8 to 3.7 seconds) for the
first 10 to 20 seconds, followed by a second, slower phase (with a
half-life of 75 to 219 minutes) that extended out to >3.0 hours. The
transition from first to second phases occurred at a concentration of
approximately 0.1 mg/ml for all four butyl nitrites and the decay
curves were first order in both phases.
Finally, similar studies were performed to examine the stability of
the butyl nitrites when incubated with mouse whole blood at 37 °C
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TABLE 3. Stability of butyl nitrites in phosphate buffer (pH = 7.4)
at 37 °C
Compound
Half-Life Minutes)
Phase I Phase II
IBN 14.0±0.7
NBN 15.2±1.8
SBN 21 .8±1.9
TBNa 5.6±0.4 16.2±2.7
aPhase l/Phase II transition at approximately 12 minutes.
NOTE: Butyl nitrites (1 mg/ml) were added to 0.1 M phosphate buffer (pH-7.4) in
septum-stoppered viaIs in a shaking incubatur at 37 °C. Samples were
withdrawn at 2 to 5 minute intervals for GLC analysis as described by
McFadden et al. 1981. Data were analyzed by feast-squares regress&n analysis;
values are reported as mean ± SEM (n=5).
TABLE 1. Stability of butyl nitrites in mouse plasma at 37 °C
Compound
Half-Life (Minutes)
Phase I Phase II
SBNa 2.79±0.16 219±65
TBNa 2.82±0.23 127±28
NBN” 3.41±0.70 162±50
lBNa 3.66±0.26 75±21
aPhase l/Phase II transition at approximately 15 seconds.
NOTE: Butyl nitrites (1 mg/ml) were added to mouse plasma in septum-stoppered vials
in a shaking incubator at 37 °C. Samples were withdrawn at 5-second to 10-
minute intervals for GLC analysis as described by McFadden et at. (1981). Data
ware analyzed by least-squares regression analysis: values are reported as mean
± SEM (n=6-7).
(table 5). Under these conditions, the rates of decay for all four
compounds were extremely rapid. NBN and IBN decayed in a mono-
phasic fashion with half-life values <2 seconds, while SBN and TBN
showed biphasic decay curves with initial phase half-life values of <3
seconds and second phase decay values of 6.1 and 20 minutes,
respectively. Thus, the breakdown of butyl nitrites was relatively
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TABLE 5. Stability of butyl nitrites in mouse whole blood
at 37 °C
Compound
Half-Life Minutes)
Phase I Phase II
NBN <1.0
IBN 1.60±0.05
SBNª 1.91±0.06 6.1±1.6
TBNª 2.72±0.26 20.2±2.3
aPhase l/Phase II transition at approximately 15 seconds.
NOTE: Butyl nitrites (1 mg/ml) were added to mouse whole blood in septum-stoppered
vials in a shaking incubator at 37 °C. Samples were withdrawn at 5 to 10
second intervals for GLC analysis as described by McFadden at al. (1981). Data
were analyzed by least-squares regression analysis; values are reported as
time ± SEM (n=4).
rapid in aqueous conditions and markedly enhanced in the presence
of mouse plasma and even more so in the presence of whole blood.
Osterloh and Goldfield (1984) have shown that NBN is rapidly
converted to n-butanol, nitrite and nitrate in water; the rapidity of
breakdown increased as the pH was lowered from 9 to 4. In whole
blood, NBN was rapidly converted to butanol and nitrate with
formation of methemoglobin; in plasma, these authors found NBN to
be relatively stable.
TOXICITY
The resultant effects of the presence of erythrocytes, coupled with
earlier observations that IP dosage of butyl nitrites (but not the
corresponding butyl alcohols) to mice resulted in discoloration of the
blood (Maickel and McFadden 1979), suggested that methemoglobin-
emia was a significant factor in the toxicity of the butyl nitrites.
Accordingly, a series of studies were performed to examine the ability
of butyl nitrites to produce methemoglobin in hemolyzed mouse
erythrocytes. The results of these studies are presented in table 6,
showing NBN as the most potent compound in this regard, closely
followed by IBN, the most commonly available butyl nitrite in
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TABLE 6. Butyl nitrite-induced methemoglobin formation in mouse
hemolyzed erythrocytes in vitro
MH 5 0 Relative
Compound (95% Confidence Linmits) Poetency
NBN 131 (180-99) 1.00
I B N 174 (211-148) 0.75
SBN 202 (295-149) 0.65
TBN 5072 (6508-4089) 0.03
NOTE: MH values are the concentration ( g butyl nitrites whole blood) necessary
to oxidize 50 percent of the Hb to metHb. Values and 95 percent confidence
limits ware datermined by the dose-response analysis of Goldstein (1964).
SOURCE: McFadden et al. 1981, Copyright 1981, Purdue University, Department of
Pharmacology and Toxicity.
commercially (street drug) available preparations. TBN was less
potent by more than an order of magnitude.
Similar data were obtained from studies in which methemoglobin
levels were determined in mice exposed to lethal concentrations of
the four butyl nitrites in dynamic inhalation chambers. In such a
test situation, death occurred in 10 to 20 minutes at the exposure
concentrations used. As seen in table 7, TBN is much less potent
than the other three butyl nitrites, with required lethal
concentrations at an order of magnitude greater. Even at this
concentration, a significantly lower level of methemoglobin was
produced by TBN as compared to the levels produced by NBN, IBN,
and SBN.
One interesting aspect of these compounds is the relatively consistent
lethal potency when given by various routes. Table 8 displays a
summary of this data as derived from LD, determinations. NBN was
the most potent compound, regardless of route of administration,
with IBN next in potency in every case. With IP dosage, SBN and
TBN were virtually identical, while with PO dosage, TBN was a bit
more potent than SBN. On inhalation, TBN was clearly the least toxic
substance by almost an order of magnitude. Similar results with NBN
have been repotted by Osterloh and Goldfield (1985).
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TABLE 7. Levels of methemoglobin in mice exposed to lethal
concentrations of butyl nitrites
Compound
Exposure
Concentration
(ppm)
Percent
Methemoglobin
NBN 2,000 97.4 ± 2.4
IBN 3,000 03.5 ± 1.7
SBN 4.000 83.1 ± 3.0
TBN 50,000 83.2 ± 2.2
NOTE: Concentrations of butyl nitrites were determined by GLC as reported by
McFadden and Maickel (1981). Methemoglobin levels were determined as
described by Frankel et al. (1970); values are mean ± SEM (n=4-5).
SOURCE: McFadden et al. 1981, Copyright 1981, Purdue University, Department of
Pharmacology and Toxicology.
Additional studies have also been performed to see if various
treatments could reduce or prevent the toxicity of these compounds.
Since most commercially available preparations contain IBN, and
several of these commercial preparations have been implicated in
human poisonings via the oral route (Dixon et al. 1981), IBN was used
as the test agent. The lethality of a PO dose of 400 mg/kg of IBN
could be significantly reduced by pretreating mice with methylene
blue (50 mg/kg, IP) or toluidine blue (50 mg/kg, IP), but not with
ascorbic acid (200 mg/kg, IP) or sodium selenite (3 mg/kg, IP). In
contrast, mice given 300 mg/kg, PO of IBN, showed no significant
antidotal effects in response to 100 percent oxygen, ascorbic acid,
methylene blue, or sodium selenite (McFadden and Maickel 1982).
These data would suggest that methemoglobinemia produced by butyl
nitrites plays a significant role in the lethality caused by these
compounds.
Further, in mice pretreated with methylene blue (50 mg/kg, IP) 15
minutes prior to a 45-minute period of exposure to 500 ppm of butyl
nitrites, methylene blue completely prevented methemoglobinemia
produced by NBN, IBN, and SBN. Under these conditions, TBN did
not produce any significant methemoglobinemia (McFadden et al.
1961). Similarly, methylene blue pretreatment significantly increased
the median lethal time values for survival when mice were exposed to
higher concentrations of all four butyl nitrites (table 9). In this
regard, Klonne et al. (1987) have reported single exposure LC50
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TABLE 8. Comparative potency (lethality) of butyl nitrites administered by different routes
IP Dosage (mg/kg) PO Dosage (mg/kg)
Compound LD50 R.P. LD 5 0 R.P.
Inhalation (ppm)
L C 5 0 R.P.
NBN 158 1.00 180 1.00 567 1.00
IBN 184 0.86 279 0.65 1,033 0.55
SBN 592 0.27 428 0.42 1,753 0.32
TBN 613 0.26 336 0.54 10,852 0.05
NOTE: IP deaths @ 0.5 hr.; PO deaths @ 2.0 hr.; Inhalation deaths @ 1.0 hr.; R.P.=relative potancy where most potent compound=1.00.
Data on IP dosage from Maickel and McFadden (1979); on PO dosage from McFadden and Maickel (1982); and on inhalation
from McFadden et al. (1981).
TABLE 9. Effects of methylene blue pretreatment on survival of mice exposed to butyl nitrites
LD50 (Minutes) Ratio Methylene
Compound Control Methylene Blue (Methylene Blue to Control) (ppm)
IBN 1500 20.5
N B N 1000 24.0
SBN 2000 43.0
TBN 50000 32.7
232.1 11.3
187.0 7.8
261.5 6.1
68.6 2.1
NOTE: Mice were dosed with 50 mg/kg, IP, methylene blue 15 minutes prior to butyl nitrite exposure. LT50 values were determined
by probit analysis.
SOURCE: McFadden et al. 1981, Copyright 1981, Purdue University, Department of Pharmacology and Toxicology.
values in rats for: ethyl, methyl, n-propyl, n-butyl, isopentyl, and
isobutyl nitrites to be 160, 176, 300, 420, 716, and 777 ppm,
respectively.
OTHER STUDIES
Finally, several studies have been performed to examine the
subchronic toxicology of butyl nitrites in mice by inhalation
(McFadden and Maickel 1985). Mice were exposed to IBN (400 ppm),
NBN (300 ppm), SBN (500 ppm), or TBN (1000 ppm) for 7 hours daily
for 60 days. Under these conditions, survival rates were 80 to 95
percent. During the first 30 days of exposure, treated animals had
significantly lower body weights than untreated controls; during the
second 30 days of exposure, the body weights of mice exposed to
IBN, NBN, or SBN returned to control values, while those of mice
exposed to TBN continued to be significantly lower than those of
controls. A summary of organ weights of these mice is shown in
table 10. Liver weight was significantly increased only in the IBN-
treated mice, kidney weight in those treated with IBN and SBN, and
lung weight in all except the mice exposed to TBN. In contrast,
spleen weights were significantly elevated in mice exposed to all four
butyl nitrites, presumably reflecting the adverse effects of butyl
nitrites on erythrocytes.
Selected enzymes were also determined in these mice. Plasma
isocitric dehydrogenase was significantly depressed in mice exposed to
TBN, liver microsomal glucose-6-phosphatase was significantly
depressed in mice exposed to IBN, and liver microsomal cytochrome
P-450 was significantly depressed in mice exposed to NBN (McFadden
and Maickel 1985).
SUMMARY
In summary, all four butyl nitrites were found to be moderately toxic
compounds in mice, especially when given PO, TBN was the least
toxic and also the least potent in producing methemoglobinemia.
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TABLE 10. Effects of 60 days exposure to butyl nitrites on organ weights of mice
Proportion of Body Weight (Butyl Nitrite/Control)
Compound Kidney Liver Lung Spleen
IBN 1.15a 1.14
a
1.74a 2.57a
NBN 1.04 0.98 1.33a 1.82
a
SBN 1.12a 0.96 1.11 1.27a
TBN 0.97 0.96 1.60
a 1.31a
asignificantly greater than control.
NOTE: Mice were treated as described in McFadden and Maickel (1985).
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The Acute Toxicity of Nitrite
Inhalants
Ronald W. Wood
INTRODUCTION
Alkyl nitrites produce a variety of effects when inhaled. Except in
the context of anginal pain or as an antidote to cyanide poisoning,
these effects cannot be construed as having therapeutic utility. A
number of demonstrable risks accompany the inhalation of these
materials, and this chapter will review the acute hazards associated
with the nonmedical use of these chemicals. Aside from the spectrum
of effects desired by the user, there are less desirable “side effects”
as well as frank injuries associated with the use of these products,
including skin and tracheobronchial irritation; bum injuries; acute
toxicity mediated by hypokinetic anoxia, methemoglobinemia, and
associated disorders of blood and blood-forming organs; and the
induction of a substance abuse disorder.
DESIRED ACUTE EFFECTS AND UNDESIRED SIDE EFFECTS
Inhalation of high concentrations of nitrites relaxes smooth muscle:
the consequent intense peripheral vasodilation produces flushing, a
fall in blood pressure, and a reflex increase in heart rate to
maintain perfusion of vital organs (Haley 1980). These effects are
accompanied by feelings of warmth, rapid pulse, and throbbing
sensations. Volatile nitrites are frequently used as an adjunct to
sexual behavior, because of their smooth muscle effects, nitrites can
reduce sphincter tone and alter tumescence. The vasodilation is
accompanied by heat loss and a subsequent chill. Headache, nausea,
and fainting are common sequelae of nitrite inhalation.
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Skin and Tracheobronchial  Irritation
Skin contact with commercial products containing butyl nitrite can
produce a crusty lesion at the site. Repetitive use of the material
can lead to a proliferation of these lesions around the nose and lip
(Fisher et al. 1981; Fisher 1984; Romaguera and Grimalt 1982) and
has been reported around the penis, the scrotum, and elsewhere (Bos
et al. 1985). The latter report suggests that a true allergic response
to these materials may occur.
The irritating properties of these materials are not confined to the
skin and have manifested themselves in tracheobronchitis with
erythema of sufficient severity to require hospitalization, and with
complaints of cough, fever, mild hemoptysis, and exertional dyspnea
(Covalla et al. 1981). Subchronic toxicity evaluations support
concern about lung injury (McFadden and Maickel1985; Lynch et al.
1985).
Burn Injuries
Aikyl nitrites are flammable and explosive. At least one bum injury
has been reported through the National injury Information Clearing
House (NEISS data base) of the Consumer Product Safety Commission
(CPSC), following the use of a room odorizer product near a candle.
“This incident involved a 26- yearold male who opened a small bottle
on a stand when it ignited, flamed up, and burned him. During this
accident, the victim spilled some of the gymnasium room odorizer
onto parts of the living room furnishings. As a result, part of an
ottoman and small sections of the carpet were damaged. lt is
believed that the liquid gymnasium room odorizer ignited, as its
vapors came into contact with a lighted cigarette in a nearby ash
tray. The victim received bums on the left side of his nose and an
area of his left cheek. The victim was also singed on his right arm,
forehead and some parts of his hair” (CPSC memo from Schmettzer to
Perez, July 11, 1977).
The materials are labeled with a warning of this hazard, which Is
not to be underestimated; small quantities have been responsible for
refrigerator explosions in laboratories, and larger quantities have
been implicated in the largest fire in San Francisco since the
earthquake of 1998 (Turner 1981). Despite these hazards, many of
the products packaged in small vials with shrink-fit plastic comply
with U.S. Postal Service regulations for the shipment of small
quantities of flammable and explosive materials.
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Acute Toxicity
Whether inhaled or swallowed, nitrites can produce anoxic states.
The administration of nitrites by any route can produce profound
methemoglobinemia. Tissue anoxemia can result from
methemoglobinemia (Darling and Roughton 1942; Lester and
Greenburg 1944). Ascorbic acid and methylene blue may be effective
prophylactic agents for nitrite poisoning if administered promptly, but
laboratory studies offer little support for this in the case of isobutyl
nitrite ingestion (McFadden and Maickel 1982). Prolonged
administration of the materials may lead to several disorders of the
Mood and blood-forming organs, including Heinz-body hemolytic
anemia and splenomegaly (Romeril and Concannon 1981); increased
spleen weight has been observed in mice chronically exposed to butyl
nitrites (McFadden and Maickel 1985). The administration of nitrites
can also produce hypokinetic anoxia, an oxygen starvation of vital
organs secondary to sustained profound peripheral vasodilation,
pooling of Mood in the extremities, and impaired vascular return
(Wilkins et al. 1937).
A number of human anecdotes report on the acute toxicity of
volatile nitrite “room odorizer” products and provide correlative
observations that substantiate concern aroused by experimental work
with laboratory animals. Severe methemoglobinemia can result from
deliberate inhalation of room odorizer products (Home et al. 1979;
Shesser et al. 1981; Guss et al. 1985). Ingestion can produce a more
rapid and malignant methemoglobinemia than can inhalation and can
be lethal (Dixon et al. 1981; Shesser et al. 1980; Shesser et al. 1981;
Smith et al. 1980; Wason et al. 1980).
The acute toxicity of the alkyl nitrites has received attention in the
laboratory and is relevant to the regulation of these materials in
interstate commerce, including packaging and labeling requirements.
A summary of these experimental findings is presented in table 1.
Room odorizer products are currently considered to be “toxic” by
inhalation or ingestion, although the oral toxicity of the material has
not been evaluated adequately according to the CPSC. The materials
display an unusually steep lethality function so that, in the effective
range, small increments in dose produce large changes in the number
of resultant deaths (Wood and Cox 1981; Klonne et al. 1987). In
addition, there is a very narrow margin of safety between
behaviorally effective and lethal concentrations (Rees et al. 1986).
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Users estimate they can derive 40 “doses” from a typical room
odorizer, yielding approximately 0.2 ml per self-administration
(lsraelstam et al. 1978). This estimate is neither a dose nor an
exposure concentration, but a rate of loss of a volatile material from
an open container. There have been no studies that describe either
the absorbed dose or the exposure concentrations that are effective
in producing smooth muscle relaxation, alterations in cardiovascular
function, behavioral impairment, or self-administration under the brief
exposure conditions typical of self-administration. However, Pryor et
al. (1989) did expose rats to isobutyl nitrite for 15 to 60 seconds, at
concentrations that increased gradually in the exposure chamber. The
LC50s expressed as a peak concentration ranged from 4.5 to 4.8
percent. The slope of the lethality function was influenced by the
rate of change of concentration. A constant concentration-time
product relationship was not obtained in this study, or in that of
Klonne et al. (1987), suggesting that the dramatic acute effects of
the agent may alter the pharmacokinetics and exaggerate the toxicity
of these agents.
For some of the aliphatic nitrites, the alcohol from which they are
synthesized may contribute significantly to their toxicity when
injected or ingested. In addition, the alkyl nitrites are metabolized
to nitrite ions and the corresponding alcohol, which may lead to
delayed deaths or hepatotoxicity. n-Butyl alcohol has an oral
median lethal dose (LD50) for the male rat of 790 mg/kg (Purchase
1969), in contrast to 13,600 mg/kg for ethanol (Smyth et al. 1941).
In an investigation of several highly pure butyi nitrites and their
alcohols given to mice intraperitoneally, set- and tert-butyl nitrites
were found to have significant delayed toxicity; the toxicity of the
alcohols by the same route was also delayed, and the LD50 ranged
from 254 (n-butyl) to 544 mg/kg (isobutyl) 7 days after
administration (Maickel and McFadden 1979).
SUBSTANCE ABUSE DISORDERS
There is clear evidence that volatile nitrites are used as drugs of
abuse. National surveys indicate that high school seniors and adults
not only have used alkyl nitrites as drugs, but also that 7.9 to 11.1
percent of high school seniors from 1979 to 1985 reported having
tried these drugs in their lifetime (Johnston et al. 1986). The
incidence of deliberate use by homosexual men has been greater and
is discussed in more detail shortly. Lowry (1980) conservatively
estimated that 250 million recreational doses a year were consumed
in the United States (Lowry 1982).
31
Volatile nitrites are persistently self-administered by people.
lsraelstam et al. (1978) interviewed 150 users of isobutyl nitrite and
reported that users who administered nitrites did so from three to
six times per “occasion”; the number of occasions ranged from only
once to four times a week. The duration that this frequency of self-
administration was maintained was unspecified. Goedert et al. (1982),
in an attempt to determine if volatile nitrites alter immune function,
studied 17 men; 10 were described as regular users, inhaling nitrites
from 1 to 20 times per month; 4 had used nitrites for longer than 6
years. Romeril and Concannon (1981) presented two cases, each of
which reported 20 sniffs per occasion, two to three times per week,
for either 3 or 24 months. Fisher et al. (1981) reported on two men
who stated that they were “in the habit” of inhaling butyl nitrite and
continued to do so during the 6-week period that they were seen by
a physician.
According to the nosological scheme of the Diagnostic and Statistical
Manual (DSM  Ill) of the American Psychiatric Association, one
definitional criterion of “substance abuse” is a duration of
pathological use for at least 1 month; several of the cases described
above meet this criterion. Other than the duration of use,
definitional criteria for “pathological use” vary with the substance
abused but may include episodes of complication due to substance
intoxication, e.g., alcoholic blackouts, opioid overdose; need for daily
use of the substance for adequate functioning; and continuation of
substance use despite a serious physical disorder that the individual
knows is exacerbated by use of the substance. Examples from the
literature fulfilling these criteria follow.
Compications Due to Substance Intoxication
Shesser et al. (1981) report a hospital admission following several
hours of continuous inhalation of an isobutyl nitrite preparation.
The patient was alert and combative, and the parents sought to have
the patient admitted to the hospital because of mental status change
and cyanosis. The patient admitted to having had several drinks of
alcohol. Treatment of the patient with oxygen and intravenous
methylene blue and ascorbic acid resulted in alleviation of the
cyanosis; with the patient becoming calmer and reoriented. Covalla
et al. (1981) report a hospital admission for severe tracheobronchitis
following the.patient’s inhalation, with a friend, of two bottles of
LockerRoom in a week’s time. Hi friend developed a similar but less
severe illness. The cases in the following paragraph also constitute
complications of substance intoxication.
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Continuation of Substance Use Despite a Serious Physical Disorder
Exacerbated by Use of the Substance
Home et al. (1979) report emergency room admission on two
separate occasions of a 25year-old man after he inhaled butyl
nitrite. The occurrence of clinically significant methemoglobinemia
was not sufficient to deter self-administration in this individual. In
a survey of 255 experienced users (Lowry 1979), 10 percent had
experienced nasal irritation at least once, and 5 percent had
experienced nausea or temporary loss of erection. These negatlve
effects were associated with “overuse” (emphasis Lowry’s). Fisher et
al. (1981) report several cases of facial dermatitis due to butyl
nitrite inhalation. Two of the three cases reported that they were
“in the habit of inhaling butyl nitrite,” and continued to do so
during the 6-week period in which the dermatitis was evident. The
skin lesions cleared when nitrite use was terminated.
Need for Daily Use of the Substance for Adequate Functioning
Sigell et al. (1978) interviewed an unspecified number of users, some
of whom claimed that they were no longer able to perform sexually
without the use of these drugs. Everett (1975) has made a similar
assertion.
CONCLUSION
Research funded by the National Institute on Drug Abuse (NIDA) has
demonstrated that drugs abused repetitively by humans are self-
administered by animals; drugs that are abused sporadically by
humans (most hallucinogens), or not at all (major tranquilizers), are
not taken by laboratory animals. Thus, there is a pharmacologic sine
qua non for the ability of drugs to maintain self-administration: in
the absence of intrinsic abuse potential, humans will not persistently
abuse a drug. Although there have been no laboratory investigations
using animal self administration preparations, volatile nitrites have
abuse potential because they would not generate persistent human
self-administration in its absence.
The extrapharmacologic determinants of substance abuse are of great
importance; in this case, the pattern of distribution, availability, and
promotion of materials in commerce play predominant roles in
elevating the abuse liability of the volatile nitrites. The pattern of
distribution of volatile nitrites is typical of a free market with access
to the mails and the right to advertise. The interruption of this
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pattern of distribution would reduce the abuse liability of these
agents.
TABLE 1. Acute toxicity of akyl nitrites
Compound Species LD5 0 /LC 5 0 Reference
Oral
n-Butyl Rat 83 mg/kg Wood and Cox 1981
(79.5-86.5) Federal Hazardous
Substances Act protocol
Ethanol vehicle
(50 mg/kg="highly toxic")
n-Butyl M o u s e 180 mg/kg McFadden and Maickel 1982
(0-288) (2-hour LD50)
sec-Butyl 428 mg/kg
(358-469)
tert-Butyl 336 mg/kg
(292-447)
Isobutyl 279 mg/kg
(0-610)
n-Butyl Mouse 171 mg/kg McFadden and Maickel 1982
(27-249) (7-day LD50)
sec-Butyl 423 mg/kg
(393-456)
tert -Butyl 308 mg/kg
(220-426)
Isobutyl 205 mg/kg
(5-311)
Intraperitoneal
Amyl Mouse 130 mg/kg Dewey et al. 1973
(111-152)
n-Butyl Mouse 158 mg/kg Mcfadden and Maickel 1979
(127-197) (30-minute LD50)
sec-Butyl 592 mg/kg
(476-734)
tert-Butyl 625 mg/kg
(520-750)
Isobutyl 169 mg/kg
(139-199)
Intravenous
Amyl Mouse 51 mg/kg Dewey et al. 1973
(38-68) (24-hours LD50)
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TABLE 1. (Continued)
Compound Species LD5 0 /LC 5 0 Reference
Inhalation
Isbuty l Mouse 1346 ppm Rees et al. 1986
(1219-1473) (30-minute exposures)
n-butyl 949 ppm
(897-1001)
Isoamyl 1430 ppm
(1302-1559)
Isobutyl Mouse 1033 ppm McFadden et al. 1981
(843-1234) (60-minute exposures)
n-butyl 567 ppm
(531-625)
sec-Butyl 1753 ppm
(1552-1964)
tert-Butyl 10852 ppm
(626-15408)
Methyl Rat 176 ppm Klonne et al. 1987
(169-183) (4-hour exposures)
Ethyl 160 ppm
(151-169)
n-Propyl 300 ppm
(293-308)
n-Butyl 4210 ppm
(410-431)
Isobutyl 777 ppm
(747-809)
Isopentyl 716 ppm
(Isoamyl) (702-731)
n-Butyl Rat 1470 ppm CPSC memo fro Perez to
(1226-1823) Preuss, September 24, 1979
Isobutyl 1000 ppm Federal Hazardous
(815-1255) Substances Act protocol
Isoamyl Rat 1118 ppm (1-hour exposures)
(797-1493)
No te : LD50=Median lethal dose (lethal to 50 percent of test subjects).
LC50=Lethal concentration, 50 percent.
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Indications From Animal and
Chemical Experiments of a
Carcinogenic Role for Iso-
Butyl Nitrite
Sidney S. Mirvish, Martin O. Ramm, and
dDavi M. Babcook
INTRODUCTlON
We have been studying the in vivo formation of carcinogenic
nitrosamines and nitrosamides (which together constitute the highly
carcinogenic N-nitroso compounds) after exposure of laboratory
animals to the atmospheric pollutant nitrogen dioxide (NO2). In the
course of those experiments, we found that the nitrite ester of
cholesterol participated in the formation of nitrosamines. This
finding is consistent with suggestions that simple nitrite esters may
form similar carcinogenic compounds in man. In this chapter we
describe experiments evaluating the carcinogenic potential of amyl
nitrite and isobutyl nitrite (IBN), a major component of abused room
odorizers, and speculate on the possible relationship between nitrite
ester abuse and the development of Kaposi’s sarcoma (KS) in patients
with Acquired lmmunodeficiency Syndrome (AIDS). We first
summarize our data on NO2 and describe the nitrite ester studies, and
then discuss the possible connections between KS and nitrite ester
abuse.
NITROSAMINE FORMATION DUE TO EXPOSURE TO NO²
In chemical systems, NO2 reacts with amines to form nitrosamines.
On this basis we studied whether the same reactions could occur in
vivo. We exposed rats to NO2 in air (50 ppm for 4 hours), gavaged
them with the secondary amine morpholine, and later analyzed the
carcasses for the corresponding nitrosamine, N-nitrosomorpholine
(NMOR). The final stage of the analysis involved gas chromatography
of the NMOR, with detection by Thermal Energy Analysis (GC-TEA),
a system that can detect as little as 0.1 ng nitrosamine. While no
NMOR was detected, the carcasses did contain a “nitrosating agent”
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that reacted with morpholine in dichloromethane or ether solution to
produce NMOR in vitro (Mirvish et al. 1981). All subsequent studies
were done on Swiss mice. The nitrosating agent was soluble in lipids
and occurred only in the skin; most of it persisted in the body for 24
hours after the NO2 exposure (Mirvish et al. 1983). The nitrosating
agent was shown to be produced by direct contact of NO2 with the
skin. Later, these findings provided some ideas about the possible
route of exposure to ISN vapor.
To identify the nitrosating agent derived from NO2 we examined the
nature of the precursor in skin lipids that reacted with NO2 to
produce this agent. About 40 percent of the precursor was associated
with the triglyceride fraction and 60 percent was identified as
cholesterol (Mirvish et al. 1986). These findings were discovered by
separation of the lipids on thin-layer and high-performance liquid
chromatography, with analysts of each fraction for a nitrosating agent
precursor. Cholesterol reacted with NO2 to produce the known
nitrite ester, cholesteryl-3-B-nitrite. Synthetic cholesteryl nitrite
reacted with morpholine by the scheme shown below to give 13
percent yields of NMOR. We showed that the cholesterol-derived
nitrosating agent in mouse skin was almost certainly cholesteryl
nitrite. These findings agreed with previous studies showing that
nitrite esters (including IBN) react fairly readily with secondary
amines to form nitrosamines (Doyle et al. 1983; Dabora et al. 1984;
Loeppky et al. 1984).
RONO + R'2NH -> ROH + R'2NNO
Thus far, we have described in vitro reactions of the N02derived
nitrosating agent to form nitrosamines. To be significant, these
reactions must also be shown to occur in vivo. To test for this, we
applied one of the secondary amines, morpholine or N-methylaniline,
to the skin of mice 20 hours after they were exposed to 50 ppm NO2
in air for 4 hours. After another 0.5 to 2.0 hours, the mice were
killed and the skins were analyzed for NMOR or N-nitroso-N-
methylaniline (NMA) by GC-TEA. We did not observe significant
NMOR, but did detect NMA, with maximum values of 18±7 nmol/mouse
(mean ± SD) for 6 mice killed 40 minutes after the amine was applied
(Mirvish and Ramm 1987). In a similar experiment, the mice were
shaved 30 minutes after methylaniline was painted, and the hair and
shaved skin were analyzed separately for NMA. The hair contained
87 percent of the NMA. This demonstrates the importance of direct
access of NO2 to the skin lipids, which should be more facile for
lipids in hair than for those in the skin itself. We attribute the
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formation of NMA, but not NMOR, mainly to the lipid solubility of
N-methylaniline, which enables this amine to react with the skin
nitrosating agent (Morpholine is not extractable by lipids at neutral
pH.) The analyses included checks to ensure that the nitrosamines
were not produced during the workup.
Lipid Peroxidation By Cholesteryl Nitrite
Nitrite esters (but not nitrate esters) absorb ultraviolet light
between 320 and 380 nm, which helps explain why nitrite esters are
decomposed by light or heat to yield alkoxy radicals and nitric oxide
(Smith 1988):
light
RON0 -> RO + NO
This reaction proceeds readily, with a free energy of 37 kcal/mol
(Gingras and Waters 1954). For this reason, methyl nitrite is used to
initiate radical reactions in studies on atmospheric pollution
(Magalhaes and Chalk 1986). lt struck us that such a reaction of
cholesteryl nitrite could be biologically significant, because radical
production is closely linked with the promotion stage of carcino-
genesis (Kensler and Taffe 1986). Lipid peroxidation is a measure of
radical production In the lipid phase of tissues and also shows
associations with tumor promotion. For these reasons, we tested
whether cholesteryl nitrite could catalyze the peroxidation of methyl
linoleate, used as a model for unsaturated lipids (Mirvish et al.
1987).
One gram of methyl linoleate, with and without the addiiion of 50
mg cholesteryl nitrite, was allowed to autoxidize in a sealed
dessicator (20 cm in diameter) for up to 7 days. To measure
autoxidation, we determined conjugated dienes end compounds (malon-
dialdehyde plus endoperoxides) that react with thiobarbituric acid
(TBA) (Buege and Aust 1978).
Table 1 shows that cholesteryl nitrite significantly increased the
production of both conjugated dienes and TBA-reacting substances.
In a preliminary experiment, painting a cholesteryl nitrite solution
(12.5 mg/250 I acetone) once on the skins of mice produced a
significant increase after 1 to 2 days in TBA-reacting material in the
skin lipids (4.5 ± 0.2 (four mice, mean  SE) compared to 0.1 ± 0
(two mice) in mice painted with acetone alone). As explained earlier,
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TABLE 1. Effect of the nitrite esters cholesteryl nitrite and IBN on autoxidation of methyl linoleatea
Yield of peroxidized material (nmol/mg methyl linoleate,
mean ± SD)
Exposure Number Conjugated diene test TBA test
Nitrite time o f Ester Ester Ester Ester
ester (days) exposures absent present absent present
Cholesteryl
nitrite
IBN
alBN results are based on weight of methyl linoleate at the beginning of the experiment. because some IBN distilled into the
linoleate. Cholesteryl nitrite results are based on weights at the time of measurement.
b*Results were sign’ificantly greater than those for corresponding samples without addition of nittrite ester, with p<0.05b or <0.01c.
these results suggest that cholesteryl nitrite could promote carcino-
genesis in mouse skin.
In Vivo Formation of the Nitrosamine NMA from Amyl Nitrite
This and the following section describe our studies on amyl nitrite
and IBN, which were based on our findings about cholesteryl nitrite.
The studies in this section demonstrated that amyl nitrite can react
to produce a nitrosamine in vivo (Mirvish et al., in press; Mirvish and
Ramm 1987).
As in the studies on skin NSA, N-methylaniline was chosen as the
test amine, mainly because it is lipid-extractable from water at
neutral pH and, hence, could react with the lipid-soluble nitrite ester,
amyl nitrite. Adult male Swiss mice were treated with methylaniline
and amyl nitrite, with each agent delivered to a different site in the
body. In the main experiment, methylaniline (250 mg/ml water/kg
body weight) was injected IP and, 30 minutes later, amyl nitrite (40
mg/ml corn oil/kg body weight) was gavaged. After another 30 or 60
minutes, the mice were killed and the carcasses were analyzed for
NMA, using the methods described earlier. For six mice killed after
30 minutes, we obtained 480 ± 310 nmol NMA/mouse (mean ± SD).
Six mice killed after 60 minutes yielded 380 ± 100 nmol NMA/mouse.
The results at 30 minutes were 18 times higher than those for NMA
produced from the N02derived skin nitrosating agent.
In a different procedure, methylaniline in water was gavaged, amyl
nitrite in corn oil was injected IP 30 minutes later, and the mice
were killed after another 30 minutes. In four mice, the NMA yield
was only 6 ± 6 nmol/mouse. When amyl nitrite, but not methyl-
aniline, was administered to four mice as in our main experiment, and
an amount of methylaniline similar to that injected IP was added to
each homogenate before the workup, NMA yield was only 5 ± 3
nmol/mouse, indicating that most NMA in the main experiment was
produced in vivo and not during the workup.
Four mice were treated as in the first experiment, with 30 minutes
elapsing between dosage with amyl nitrite and sacrifice, and certain
tissues were analyzed for NMA. These yielded 630 ± 140 (stomach
contents), 90 ± 2 (stomach wall), 9 ± 3 (liver), 5 ± 3 (intestines plus
contents), and 0.5 ± 0.3 (Mood) nmol NMAI/mouse. Hence, most NMA
was produced at the site of delivery of the amyl nitrite. These
results demonstrate that simple nitrite esters can produce large
yields of nitrosamine in vivo, if a lipid-soluble amine is supplied. In
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humans, exposure to volatile nitrite esters could produce
carcinogenic N-nitroso compounds from endogenous or exogenous
amines, or, perhaps, from N-substituted amides (which can be more
lipid-soluble than most amines).
In Vitro Enhancement of Lipid Peroxidation by IBN
We have described our finding that cholesteryl nitrite enhanced the
autoxidation of methyl linoleate. We have now repeated this
experiment using IBN. Since IBN is volatile, methyl linoleate (0.5 g
in an evaporating dish), was placed in a sealed glass tank (8 x 21 x
28 cm) also containing a beaker with 2 ml IBN. After 4 to 5 days,
some IBN had distilled into the linoleate and IBN in the beaker was
replenished. As a control, methyl linoleate was stored in a similar
tank without IBN. Table 1 shows that IBN significantly enhanced the
formation of lBA-reading material but (unlike cholesteryl nitrite) did
not affect (or even reduce) the level of conjugated dienes. This
indicates that IBN increased the prcduction of endperoxides, but not
that of hydrcperoxides.
In conclusion, the nitrosamine formation and lipid peroxidation
experiments suggest that IBN could be carcinogenic in man, either
because it produced carcinogenic N-nitroso compounds in vivo, or
because it enhanced lipid peroxidation in vitro and hence could be a
tumor promoter.
POSSIBLE ASSOClATlON BETWEEN EXPOSURE TO IBN AND KS IN
AIDS
At about the time we were studying cholesteryl nitrite, Newell et al.
(1985) proposed that IBN could produce N-nitroso compounds in vivo,
which in turn could potentiate the induction of AIDS or KS
associated with AIDS. After the role of human immunodeficiency
virus (HIV) in AIDS was discovered, emphasis shifted to the second
of these hypotheses.
About 15 to 25 percent of U.S. homosexual males with AIDS have
developed KS; this cancer is often the cause of death (Leu and
Odermatt 1985; Safai et al. 1985; Biggar et al. 1985). Heterosexual
AIDS patients have a much lower incidence of KS (Haverkos et al.
1985). KS also occurs in immunosuppressed patients who do not have
AIDS, but at far lower incidences than in homosexual AIDS patients
(Friedman-Kien et al. 1982). Hence, KS in AIDS appears to be
associated with the lifestyle of homosexual men in the United States.
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Haverkos et al. (1985) reported a significant association of KS in
homosexual male AIDS patients with their exposure to IBN measured
as total days of use.
There is evidence both for and against nitrites being involved in the
genesis of AlDS associated KS. In addition to Involvement in the
formation of nitrosamines, IBN is mutagenic in the Ames test
(Osterloh and Goldfield 1984), and Dax (this volume) reports an
immunosuppressive  action of IBN that could contribute to cancer
induction. However, three points argue against the involvement of
IBN in the etiology of AIDS associated KS. First, the increased
incidence of KS in heterosexual AIDS patients in Africa is unlikely to
be associated with nitrite abuse (Kestens et al. 1985; Marquart 1986).
Second, there is some suggestion that concurrent cytomegalovirus
infection is associated with KS in AIDS (Safai et al. 1985). Third,
amyl nitrite was used for many years to treat angina pectoris without
any evidence of a carcinogenic effect.
Possible Routes of Access of IBN to the Tissue of Origin for KS
KS is a cancer of the endothelium of blood vessels (Leu and
Odermatt 1985) or lymph vessels (Beckstead et al. 1985; Jones et al.
1986). The main sites of origin for KS in AIDS are the dermis of
the skin or (less often) the submucosa of the oral cavity (Safai et
al. 1985; Volberding 1986). Common sites in the skin for AIDS-
associated KS are the upper body, arms, and head, including the tip
of the nose. The tumor is often multicentric in origin, illustrating
the potency of the etiologic agents (Safai et al. 1985).
We favor the hypothesis that, if IBN is involved, its route of access
is by direct contact to the skin or oral mucosa with airborne IBN
vapor. This could occur directly when IBN is sniffed, which would
explain the site at the tip of the nose, or by general exposure to IBN
vapor inhaled by the subject or by others in bars, bathhouses or
homes (Lauritzen and Wilson 1986). (These places often smell
strongly of IBN, as reported at this meeting.) Hence the location of
the sites for AIDS-associated KS support our hypothesis about direct
contact with IBN vapor. This idea was suggested by our finding that
exposure to NO2 (which, like IBN vapor, is a lipid-soluble  gas) results
in nitrosating agent formation only in the skin.
Another possibilit y is that IBN vapors are absorbed by the lungs and
travel to the skin via the bloodstream. In support of this view,
sniffed IBN does reach the peripheral blood vessels, where it
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produces vasodilation (Needleman et al. 1985), and the brain, where
it produces a “high” sensation. This view could be valid, even
though IBN may only persist in the body for about 1 minute after it
is sniffed (the time for which the flushing and high feeling persists).
Needs for Research on IBN in Laboratory Animals
Research on the action of IBN in experimental animals would serve
to establish more firmly whether IBN is a likely factor in the
etiology of KS, and perhaps B-cell lymphoma (Levine et al. 1984;
Biggar et at. 1985; Ziegler et al. 1 984), associated with AIDS.
Specifically, we propose that research should be undertaken: (1) to
determine whether IBN can be an initiator and/or a promoter of
carcinogenesis; (2) to determine the route of access of IBN to the
dermis; and (3) to establish the mechanisms of any carcinogenic
effects of IBN.
With respect to point (1), initiation of carcinogenesis is a single,
rapid event, probably involving a mutation of the DNA. Promotion of
carcinogenesis is a second stage and usually involves chronic
exposure to the active agent. In man, lBN could initiate carcino-
genesis via the formation of N-nitroso compounds or by a direct
reaction with DNA, and HIV could promote KS development, probably
via its immunosuppressive action. Alternatively, HIV could initiate
and IBN could promote KS development, perhaps via its effect on
lipid peroxidation. A determination of whether IBN initiates or
promotes carcinogenesis would help epidemiologists decide whether to
estimate IBN exposure before or after infection with HIV.
Hence, we recommend carcinogenesis tests to determine whether IBN
is: (1) a complete carcinogen, (2) a promoter of carcinogenesis,
especially in the skin, and (3) a cocarcinogen with viruses, including,
if possible, HIV in chimpanzees and feline leukemia virus in cats.
These tests should be done with IBN administered systemically and by
exposure to its vapors.
We further recommend metabolic studies, which should also be
performed with IBN given systemically and by exposure to its vapors.
These studies will establish the conditions under which various
N-nitroso compounds and nonvolatile nitrite esters (which could be
long-lasting indirect sources of N-nitroso compounds) are produced
from IBN; determine the distribution and metabolism of IBN in the
body, including its conversion to inorganic nitrite (which is also a
vasodilator); determine whether tissue lipids can be peroxidized by
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IBN; and test for DNA damage caused by IBN, including the induction
of single-strand breaks and base alkylation (since these types of
damage could result in tumor initiation).
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Toxicity of Inhaled lsobutyl
Nitrite in BALB/c Mice: Systemic
and lmmunotoxic Studies
Daniel M. Lewis and Dennis W. Lynch
INTRODUCTION
Initial epidemiologic studies of the outbreak of acquired immuno-
deficiency syndrome (AIDS) among homosexual men indicated that the
use of organic inhalant nitrites (poppers) such as amyl nitrite and
isobutyl nitrite (IBN) was a possible risk factor in the development of
this disease (Centers for Disease Control (CDC), 1982). Although
subsequent studies have shown that the human immunodeficiency virus
(HIV) is the etiological agent of AIDS (Popovich et al. 1984), the
possible role of inhalant nitrites as a cofactor in some of the
illnesses associated with this syndrome has not been excluded.
The use of inhalant nitrites has been reported to be associated with
altered ratios of T-helper and T-suppressor cells (Goedert et al.
1982), but other studies failed to confirm this observation (Kornfeld
et al. 1982). In vitro studies have been reported that show that
volatile nitrites can inhibit the responses of mononuclear cells (Hersh
et al. 1983; Jacobs et al. 1983), but the in vivo effects of these
compounds on the immune system have not yet been reported. The
pharmacological and toxicological properties of these compounds have
been reviewed (Haley 1980; Jackson 1979), and the reported effects
include dizziness, headache, tachycardia, syncope, hypotension,
increased intraocular pressure, and production of methemoglobinemia
(Bruckner and Peterson 1977). In addition, volatile nitrites have been
shown to be direct mutagens (Quinto 1980), and are highly flammable.
Thus, it is apparent that these chemicals are hazardous, but their
immunotoxic properties have not been fully evaluated.
The National Institute for Occupational Safety and Health (NIOSH),
as one of the Centers for Disease Control, was requested by the
CDC Task Force on AIDS Activity to perform an immunotoxicologic
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evaluation of aliphatic nitrites utilizing the NIOSH High Risk
Exposure Chambers. IBN was selected as the test chemical primarily
because IBN could be obtained and maintained in a more chemically
pure state than amyl nitrite. IBN is used as an inhalant, and all
volatile nitrites are thought to have similar physiologic effects (Haley
1980). Mice were exposed to various concentrations of IBN and at
selected time intervals removed from the chamber and tested for
immunocompetency by a variety of techniques. Since there was a
general lack of toxicologic data on organic nitrites and on IBN in
particular, the subchronic inhalation toxicity of IBN was evaluated
concurrently with the immunotoxicity assessment. Exposures were
selected to mimic an occupational exposure setting in order to fill
this gap in the existing literature, rather than to conduct brief,
acute, high-level exposure to imitate exposure by nitrite abusers.
The results of that study are the subject of this report.
EXPERIMENTAL  PROTOCOL AND METHODS
The exposure conditions and experimental protocol have been
described in detail previously (Lynch et al. 1985; Lewis et al. 1985).
Briefly, BALB/c mice were exposed to 300 ppm of IBN vapors in
inhalation chambers for 6.5 hours/day, 5 days/week, for up to 18
weeks. The IBN chamber concentrations were monitored hourly using
a Miran IA infrared analyzer (Foxboro-Wilkes, Norwalk, CT) and flow
rates adjusted to maintain exposure concentrations at the target
level. Individual body weights for exposed and control animals were
recorded weekly, and all mice were observed twice daily for clinical
signs, morbidity, and mortality. At selected time intervals, mice were
randomly selected and removed from the exposure chambers and killed
with an overdose of pentobarbital sodium. A blood sample was
obtained for hematological testing, and the spleen, liver, and thymus
removed and weighed. After weighing, the spleens were teased apart,
filtered through an 80-mesh wire screen, and the cell suspension
collected in Hanks balanced salts solution (HBSS). The cells were
washed in HBSS, counted, and divided into three portions. One
portion was used to enumerate antibody-producing cells (Dresser
1978) (a measure of B-cell function), one portion was used for the
lymphocyte blast transformation assay (LBT) (Luster et al. 1981) (a
measure of T-cell function), and the third portion was used to
enumerate the T-cell subpopulations by immunofluorescence staining
using monoclonal antibodies specific for mouse Thy-1.2, Lyt-1 , and
Lyt-2 antigens.
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A separate group of animals was used to evaluate cellular immune
reactivity in vivo by means of a radiometric skin test procedure
(Luster et al. 1981). Briefly, 10 IBN-exposed and 10 control animals
were immunized wlth Freund’s complete adjuvant, which contains
mywbacteria, 21 days prior to sacrifice. The animals remained in the
exposure chambers during this time. Two days prior to sacrifice they
were injected with tritiated thymidine (1.0 uCi/g body weight).
One day later the animals were skin tested by injection of 10µl of
PPD antigen into the right ear and 10µl of saline into the left ear.
Twenty-four hours after skin testing, the mice were killed, the ears
excised, and the radioactivity of each ear determined. The ratio of
iritated thymldine counts in the right and left ear was calculated to
provide an index of antigen-induced inflammation.
RESULT AND DISCUSSION
lmmunotoxic effects may be associated with a decline in the general
health of an animal. For thii reason, the body weights of the mice
were monitored weekly during the exposure period, and at
termination of the experiment. No significant differences in weight
gain were noted during the exposure period and, as shown in table
1, the terminal body weights were not significantly different. Also
shown in table 1 are selected organ weights for mice exposed to 300
ppm of IBN for 13 weeks. The liver weights of exposed males and
the thymus weights of exposed females were statistically
significantly less than the controls, but these changes could not be
related to any gross or histopathological damage in the organs.
Histopathologic examinations were made of a number of tissues of
these animals, and the only agent-dose-related change noted was
focal hyperplasia of the bronchiolar epithelium.
Hematological evaluations of the mice included red cell counts
(RBC), white cell counts (WBC), hemoglobin, and methemoglobin
determinations. In table 2, the results of these analyses are shown.
As expected, the exposure to IBN did induce methemoglobin
formation. The exposed males also showed lower WBC values than
the controls, but these changes were not related to any observed
changes in the bone marrow cytology. Depressed WBC counts were
not seen in mice exposed to lower concentrations of IBN, nor in the
females exposed to 300 ppm; the significance of this observation is
unclear.
Several assays were performed to evaluate the immune system of the
exposed animals. To evaluate the antibody-producing capabilities of
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TABLE1. Organ and body weights in mice exposed to 300 ppm of
IBN for 13 weeks
Exposure Methemoglbin
Group RBC W B C Hemoglbin (numbe pos/
(millions/ml3) (millions/ml
3) (thousands/ml3) (g/dl) number tested)
Males
Exposed 9.5±0.8 2.4±0.8* 15.5±1.3 5/5
Control 9.0±1.1 6.4±1.9 16.0±0.5 0/5
Females
Exposed 9.0±0.9 5.4±1.7 15.9±0.4 3/5
Control 9.6±1.1 5.4±3.0 16.3±1.1 0/5
Exposure
Group Body Wt. (g) Liver (g) Spleen (mg) Thymus (mg)
Males
Exposed 31.4 1.94* 197.6 38.9
Control 31.7 2.14 199.5 40.1
Females
Exposed 25.4 1.53 231.3 33.0*
Control 24.9 1.56 186.3 45.2
*Statistically significant differnece versus controls, p<.05
NOTE: There was 15 mice/sex/groups.
TABLE 2. Heamtologic data from mice exposed to 300 ppm IBN
for 13 weeks
*Statisticaly significant from control, P<.05.
the mice, selected animals were immunized with sheep red blood cells,
and plaque assays for antibody-producing spleen cells were performed.
lt should be noted that the mice continued to be exposed to IBN
between the time they were immunized and the time the assay was
performed (4 days). As shown in table 3, the female mice exposed to
300 ppm IBN for 18 weeks had significantly higher numbers of
antibody-producing cells than did the controls. At no other time
period or dose level were there any statistically significant
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differences Between exposed and control animals. These results do
demonstrate that mice can develop an antibody response (humoral
response) while being exposed to IBN.
TABLE 3. Enumeration of antibody-poducing spleen cells in mice
exposed to 300 ppm IBN for 18 weeks
*Statisticaly significant from control, P<.01.
To evaluate the cellular immune response, mice were immunized and
tested for a delayed hypersensitivity response using a radiometric
skin test assay. Thii assay was only performed on animals that
had been exposed to 50 ppm IBN for 7 or 13 weeks.
Positive skin test responses were obtained with both the IBN-
exposed and control animals (table 4). The exposed animals had
slightly higher mean values, but the differences were not
statistically significant. The results demonstrate that the animals
can develop a cellular immune response while being exposed to IBN.
The cellular immune responses were further evaluated using an in
vitro assay. The LBT assay, which measures the proliferative
response of splenic lymphocytes to known mitogens, was performed;
results are shown in table 5. Each mitogen was tested at several
concentrations; the results shown are for the optimal concentration
of each mitogen. Only animals exposed to 300 ppm IBN for 18
weeks showed any significant differences in the LBT assay, and, at
that time point and for each mitogen, the exposed animals were
consistently more responsive than the controls. lt is of interest to
note that in the control cultures, i.e., those cultures that received
no mitogen and measured the background level of proliferation by
the splenic lymphocytes, the IBN-exposed animals had significantly
higher levels of thymidine incorporation. lt has been shown that
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Plaque Counts
(Mean number of Plaque-Forming Cells per 10° Spleen Cells)
Animals Number Exposed Control Exposed/Control
x 100
Males 5 206±63 199±57 104
Females 5 334±73 129±35 259*
Total 1 0 270±93 164±58 165
TABLE 4. Radiometric determination of the skin test sensitivity
of mice exposed to 50 ppm IBN for 7 or 13 weeks
Ratio of Tritiated Thymidine per mg Tissue of Antigen-Injected Ear/Saline-Injected
Ear. Mean ± SE
Weeks of Exposure
Treatment Number 7 13
Exposed 10 2.98±0.51 2.49±0.69
Controls 10 1.77±0.15 2.19±0.39
TABLE 5. Results of the LBT assay performed on mice exposed to
300 ppm IBN for 18 weeks
Mitogen Number Exposed Controls
Phytohemagglutinin 10 67815 ± 9477* 40288 ± 6177
Concanavalin A 1 0 64096 ± 12948 43628 ± 6811
Pokeweed Mitogen 10 9570 ± 1885* 2887 ± 536
Lipopolysaccharide 10 15724 ± 2312* 5718 ± 884
Control (no mitogen) 10 4596 ± 998* 1422 ± 166
*Statistically significantly difference from control p<.01
NOTE: Results expressed as the mean + SE of cpm of trithted thymidine
incorporated for the group. Each animal was tested in replicates of four and
the mean value for each animal averaged to give the group moan.
organic nitrites can stimulate guanylate cyclase and increase cyclic
guanosine monophosphate (cGMP) levels (Ignarro et al. 1981). An
increase in cGMP levels occurs during the initiation of a
proliferative response by lymphocytes (Hadden and Coffey 1982).
Thus, it is possible that the chronic exposure to IBN may have
altered the responsiveness of the lymphocytes to the mitogens or
caused the increased background proliferative response seen by
affecting the cGMP metabolism. The biological significance of an
enhanced LBT response is unclear. Additional studies are needed to
determine if this response correlates with resistance to infection,
incidence of autoimmune phenomena, or possibly an increased
incidence of tumors.
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One of the first immunologic abnormalities recognized in AIDS
patients was an alteration in ratio of Tcell subpopulations,
i.e., an inversion of the ratio of T-helper to T-suppressor cells. For
this reason, we determined the percentage of spleen cells expressing
either Thy 1.2, Lyt-1, or Lyt-2 surface antigens. The Thy-l antigen
is common to all mature T-cells in the mouse. The Lyt-2 antigen is
analogous to the CD-8 antigen in man (the suppressor/cytotoxic T-
cell subset), and the Lyt-1 antigen is found predominantly on the
helper/inducer subset of T-cells in mice but is expressed at low levels
on all peripheral T-cells (Ledbetter et al. 1961). Using a fluorescent
microscope, we could not accurately enumerate the helper
subpopulation. Thus, the ratio of helper to suppressor cells could
not be calculated. As shown in table 6, there was no difference in
percentages of cells expressing these markers in the IBN-exposed
animals. The ratio of Lyt-2 to Thy-l cells was not different, which
indirectly indicates that there was no depletion of the helper cell
subpopulation.
TABLE 6, Relative number of spleen cells expressing Thy-l.2
Lyt-1 or Lyt-2 antigens in mice exposed to 300 ppm IBN
for 18 weeks
(Mean ± SD)
Percentae of Cells Expressing Ratio of
Treatment Group Thy 1.2 Lyt-1 Lyt-2 Lyt-2/Thy-1.2
Exposed (10) 31.4±3.6
2
34.2±5.1 19.8±2.8 0.634±0.085
Control (10) 35.5±3.5 38.6±5.1 21.8±3.1 0.616±0.092
CONCLUSION
The results obtained in this study indicate that, at the levels tested,
IBN had no significant detrimental effect on the immune system of
mice. The toxic effects noted included methemoglobinemia and focal
hyperplasia of the bronchiolar epithelium. Thus, while IBN may not
be an immunotoxicant, it was not totally innocuous in this study.
Numerous other toxic effects of this chemical have been reported by
others (Haley 1960; Jackson 1979; Brudner and Peterson 1977), and it
should be considered a hazardous substance. Finally, inhalant nitrites
may not be responsible for the basic immune defects characteristic of
AIDS, but their role as a cofactor in some of the illnesses associated
with this syndrome cannot be ruled out.
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Altered T-Cell Helper/Suppressor
Ratio in Mice Chronically Exposed
to Amyl Nitrite
Jesse. Oritz and Vilma L. Rivera
INTRODUCTION
Amyl nitrite (AN) and other volatile nitrites have become popular
over-the-counter drugs that are inhaled to alter consciousness,
enhance meditation, stimulate dancing, and intensify sexual
experience.
The drug was first used in 1867 as a treatment for patients suffering
from anginal pain (Sigell et al. 1978). When the Food and Drug
Administration designated AN a prescription drug in 1968, butyl and
isobutyl nitrite (IBN) were used as substitutes on the street (Cohen
1981). Presently, these aliphatic nitrous acid esters are marketed in
small vials (10 to 30 ml) or in small, thin glass capsules (0.18 to 0.30
ml) covered by cloth webbing that may be crushed by the fingers
prior to inhalation. These are usually referred to as "poppers." In
the United States, approximately 5x107 to 15x107 ml per year of AN
are used (Haley 1980; Nickerson et al. 1979).
Dewey et al. (1973) examined the behavioral and toxicological effects
of AN in mice and dogs. When intravenous (IV) and intraperitoneal
(IP) routes of administration were employed, the medial lethal dose
(LDs50) and its 95 percent confidence index for AN in mice was found
to be 130 mg/kg by the IP route and 51 mg/kg by the IV route.
When 22 vials 300µl/vial) of AN were administered to dogs by
inhalation every 30 seconds, the animals exhibited Irritability,
tremors, ataxia, and defecation.
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The Centers for Disease Control (CDC) (1983) reported that IBN had
no immunotoxic effect on mice exposed to vapors at concentrations of
20, 50, and 300 ppm for up to 18 weeks.
Other investigators have shown that inhalation of AN also relaxes
most smooth muscle structures, e.g., bronchial, gastrointestinal,
rectum proper, and internal anal sphincter muscles (Sigell et al. 1978;
Haley 1980; Nickerson et al. 1979). In humans, AN may be dangerous
to those who have had cerebral hemorrhage, hypotension, glaucoma,
and myocardial disease (except patients with artery spasm) due to its
hypotensive and tachycardiac effects (Jorgensen and Lawesson 1982).
Recent reports suggest that AN may be a contributing cofactor to
AIDS in the homosexual population (Jorgensen and Lawesson 1982;
Goedert et al. 1982; Digiovana and Safai 1981). Further, Goedert et
al. (1982) have suggested that use of nitrites may play a role in the
imbalance of T-cell ratios among the healthy homosexual population.
While Goedert’s hypothesis could not be substantiated by other
workers (Durack 1981; Jaffe et al. 1983), in vitro studies using IBN
have demonstrated impaired lymphocyte and monocyte function at 1
percent concentration but not at 0.5 percent (Hersh and Reuben 1983;
Mayer 1964; Newel et al. 1984). The results demonstrated that these
effects were irreversible after 24 hours of exposure. At lower
concentrations the drug inhibited lymphocyte blastogenesis, natural
killer cell activity, antibody-dependent lymphocyte-mediated
cytotoxicity, in vitro cell adherence, and transformation of monocytes
to macrophages. These agents also inhibited leucine, uridine, and
thymine incorporation and inhibition of interferon production by
fibroblasts. These inhibitory effects were detectable even at 0.01
percent concentrations. Further, Osterloh and Goldfield (1984)
showed that wmmon “street” preparations were effective nitrosating
agents at neutral pH. In a recent report presented in Atlanta at the
CDC International Conference on AIDS, Haverkos et al. (1985) studied
a group of AIDS patients and by multivariance analysis showed that
inhalation of nitrites was the most common factor in the genesis of
Kaposi’s sarcoma, a skin cancer commonly associated with AIDS.
In view of these reports, there is an ongoing reevaluation on the
effects of alkyl nitrites and their relationship to opportunistic
infections and Kaposi’s sarcoma in AIDS patients. As part of this
reevaluation, this project studied the in vivo effects of AN on T-cell
function.
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METHOSDS AND MATERIALS
After a 5-day acclimation period, 4-week-old male Charles River Labs
CD-1 mice, weighing from 16 to 22 g, were placed in stainless steel
cages in a light and dark temperature controlled room. Paired mice
were then fed Purina Rodent Chow and distilled water ad libitum.
The mice were then exposed to distilled AN via inhalation 5 days a
week for 21 weeks. Preliminary exposure showed that one 10µl dose
of AN was lethal to mice. For this reason, animals were slowly
acclimated to the substance by increasing doses as shown in the
protocol. The control group was given the same amount of saline
solution (0.85 percent NaC). To insure inhalation, the AN or saline
was introduced intranasally to a single group of 50 mice using a
10 I micropipette. Mice were exposed as follows:
Exposure Time
Time Since
First Exposure Amount AN Cumulative
(Weeks) (Weeks) Given per Day Amount Given
(µl) (µl)
Following exposure, mice were weighed and randomly assigned to
group I or group II.
Group I: Listeria monocytogenes (LM) Challenge
A group of 20 mice (10 exposed and 10 control) was randomly
selected after a 13-week exposure time and challenged intranasally
with 50 µl of an ID50 dose of the facultative intracellular pathogenic
bacterium LM, containing 2.8x106 organisms per ml. These mice were
monitored for mortality death up to 14 days.
Group II: T-Cell Depletion
T-cell depletion was assessed with the remaining group of mice (14
control and 11 exposed) after a 21 -week exposure time. The
monoclonal antibodies assay was used to measure different T-cell
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subpopulations. Total T cells (Thy-l), helper T cells (Lyt-2
negative), and killer T cells (Lyt-2 positive) were measured using
peripheral blood. The bound target antigens were revealed with a
fluorescein-labeled goat antirat immunoglobulin G (IgG) (no cross-
reactivity with mouse IgG) (Cappel Labs).
Blood was obtained by cardiac puncture on Iightly anesthetized mice
using a 23-gauge needle attached to a l-ml syringe containing 100
units of heparin. A semi-microtechnique was used to isolate the
peripheral blood lymphocytes (Ledbetter and Hersenbrg 1079).
Heparnized blood was fractionated by the Ficol-Hypaque gradient
centrifugation technique. The washed lymphocytes were Incubated for
45 minutes with the corresponding antibodies. Excess antibodies were
washed off and the pelleted cells resuspended with the corresponding
flourescien antibodies for 45 minutes. The reaction was
stopped by the addition of 2 percent paraformaldehyde and centri-
fuged, and the sediment was resuspended in 1 to 2 drops of
phosphate-buffered saline (PBS) containing 30 percent v/v glycerol.
These cells were observed under the fluorescent microscope.
The mice were then killed and the spleen, kidneys, lungs, and livers
collected. The organs were then washed with sterilized PBS, dried,
and weighed. Anatomical observations were made for gross pathology.
The organs were preserved in Formalin (10 percent) for further
studies.
STATISTICAL ANALYSIS
Student’s t test was used to test the null hypothesis that exposure of
mice to sublethal doses of AN does not affect the following
parameters: pathotoxicology (repeated measurement of weight, weight
gain, and organ/body weight ratio and cellular Immunity); and T-cell
differential count.
In addition, regression analysis was used to measure the relationship
between T-cell ratio and the independent variables of body weight
and weight gain in group 2.
RESULTS
Host Resistance to LM
Lewis et al. (1983) demonstrated that there were no effects after
exposing mice to IBN vapors for 13 weeks. Since our animals were
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exposed to IBN by the intranasal route (a slightly different method),
we decided to check our experimental animals for signs of immune
imbalance after 13 weeks by challenging them to an LD50 of LM.
Results shown in figure 1 indicate 20 percent of the exposed mice
and 40 percent of the controls survived this challenge; however, no
significant statistical differences (p>0.05) were observed in the
survival time of the two groups.
FlGURE 1. Days following LM challenge
NOTE: Effect of AN on mice survival following intranasal challenge with LM
(pathogenic). Significance was determined by Fisher’s exact test: p>0.05.
T-Cell Depletion
Results of T-cell differential counts are summarized in table 1.
Further, relationships between T-cell helper/suppressor ratio (T-cell
H/S ratio), body weight, and weight gain were analyzed (see table 2).
As seen in table 1, the total T cell and suppressor (Lyt-2 positive)
cells did not differ significantly between the two groups (p<0.1578
and p>0.4387, respectively). However, a significant decrease was
observed in helper (Lyt-2 negative) cells (p<0.0037). As a result,
there was a significant shift in the helper to suppressor ratio
between the two groups.
Furthermore, a significant degree of correlation (p<0.01) was found
between T-cell H/S ratio and the independent variables of body
weight and weight gain in the exposed group (table 3).
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TABLE 1. Evaluation of T-cell different count folbwing AN exposure (group 2)
Total T-Cell % from Lyt-2 Negative
T-Lymphocyte Lyt-2 Negative Lyt-2 positive Lyt-2 Positive
Number (Mean ± SE) *(Mean ± SE) (Mean ± SE) *(Mean ± SE)
Control 41.22 37.74 24.60 1.53
(14) (±2.89) (±3.81) (±1.96) (±0.24)
Exposed 35.55 20.88 27.99 0.75
(11) (±2.37) (±3.44) (±4.18) (±0.10)
p (value) =>0.1578 =<0.0037 =>0.4387 =<0.005
*Student’s t test was used to mean values. Level of significance p<0.01.
Pathoxicologic Parameter
Mouse body weight and rate of weight gain after termination of each
exposure time are represented as means of each group (tables 2 and
4). A decrease In mean body weight was found after an accumulative
exposure time of 8 weeks (data not shown) and continued until the
end of the experiment (see table 2). After 21 weeks of exposure
time, both body weight and weight gain rate were significantly
decreased p<0.02; p<0.05, respectively). When the organ to body
weight ratio was evaluated (table 5), no significant differences were
found between the two groups. However, examination of lungs,
TABLE 2. Mouse body weight of group 2 following AN exposure
(T-cell depletion)
Control Exposed Level of
(±SE) (n=14) (±SE) (n=11) Significance*
Body Weight Mean 37.62 37.62 34.48 p<0.02
(g) (1.06) (1.12)
Weight Gain Mean 18.37 T e x t p<0.05
(g) (0.86) (1.11)
*Student’s t test was used to compare mean values. A value of p<0.05 was
considered stastically significantly. Total AN=655µl.
spleen, liver, and kidneys of mice exposed to AN showed extensive
damage to the lungs (table 6), which was statistically significant
(p<0.01). Lung damage consisted of (1) hemorrhagic spots; (2)
petechiae throughout the lobes; (3) collapsed consolidated sections,
which were red and showed the appearance of emphysema; and (4) air
pockets with large air bubbles. These gross pathological observations
were made in 10 of 11 mice. Spleens in 3 of 11 mice in the exposed
group were edematous and showed dark hemorrhagic spots. In the
control group, the lungs were normal in 11 mice and edematous in 3.
The spleens were normal in 11 mice and edematous without
hemorrhagic spots in 3 of the controls; and kidneys and livers
appeared normal in both groups.
65
TABLE 3. Relationships between T-cell H/S ratio, body weight, and
weight gain in mice following AN exposure
Group
Studied Correlation Coefficient (r)*
(n) T-cell H/S Ratio:Body Weight T-Cell H/S Ratio:Weight Gain
Control -0.471 (p>0.05) -0.308 (p>0.05)
(14)
Exposed 0.867 (p<0.01) 0.792 (p<0.01)
(11)
*Regression analysis was used to compare the relationships between the variables
mentioned above. A value of p<0.05 was considered to be statistically correlated.
DlSCUSSION
In summary, the results presented here demonstrate that exposure to
sublethal doses of AN can cause a significant decrease in helper cells,
thus resulting in an inverted T-cell H/S ratio. Mean body weight
decreased after 8 weeks and became statistically significant by the
end of 21 weeks of exposure. The cellular immunity parameter (T-
cell H/S ratio) showed a statistically significant correlation coeffi
cient between T-cell H/S ratio and the independent variables of body
weight and weight-gain rate. Thus, as T-cell H/S ratio decreased,
weight gain also decreased. The gross pathological observation of
selected organs also showed statistically significant damage to the
lungs in the exposed group.
The fact that no correlations between T-cell H/S ratio and the
independent variables were detected in the control group indicates
that the positive correlation detected in the experimental group may
be a reflection of AN’s toxic effect.
Another parameter tested was the resistance of exposed mica to
pathogenic intracellular LM, used to assess the competence of T-
lymphocytes and macrophages. Peak resistance was reached on day 6
for the control group (40 percent survival) but was delayed until day
14 (20 percent survival) in the exposed group.
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TABLE 4. Mouse body weight and weight gain following AN exposure and challenge with pathogenic LM
*Student’s t test was used to compare mean values. A value of p<0.05 was considered statistically significant. Total AN=265 µl.
Control Exposed Level of
(±SE) (n=10) (±SE) (n=10) Significance*
Body Weight Mean 36.1 33.4 p<0.05
(g) (0.84) (0.82)
Weight Gain Mean 12.1 13.06 p<0.25
(g) (1.07) (0.78)
TABLE 5. Relative* and absolute** organ weights of group 2 following AN exposure
Group Spleen Lung Liver
Studied Organ Mean*** Mean*** Mean***
(n) Weight (±SE) (±SE) (±SE)
Control Relative 0.227±0.083 0.584±0.024 6.47±0.247
(14) Absolute 0.089±0.037 0.229±0.089 2.55±0.105
Exposed Relative 0.235±0.010 0.623±0.023 6.14±0.118
(11) Absolute 0.086±0.005 0.227±0.081 2.21±0.061
*Relative=orgsn weight/body weight.
**Absolute=organ weight.
***Studant’s t test was used to compare the mean value. A value of p>0.05 was not considered statistically significant.
TABLE 6. Pathological (gross) obsetvations of the lungs following
AN exposure (group 2)
Lungs
Normal Abnormal
Control (n=14) 11 3
Exposed (n=11) 1 10
Total 12 13
NOTE: Level of significance: p<0.01.
These results could be misleading since challenge to LM was done
after only 13 weeks of exposure time. Other workers have not shown
any effects after exposing mice for 13 weeks. The mice received a
total of only 385 I of AN, which is apparently not sufficient to alter
survival in vivo, although it might be extremely toxic in vitro. Had
this parameter been tested at 21 weeks, there could have been a
statistically significant difference.
Inhalation of AN produces effects similar to nitrous acid and N-
nitroso compounds. Several studies (Maigetter et al. 1978;
Gardner et al. 1977; Fenter et al. 1973; Holt et al. 1979) have
reported depression of cellular immunity of various animal species
following NO2 exposure. Holt et al. (1979) exposed BALB/c mice to
10-ppm NO2 for 30 weeks, and examination of lung pathology showed
peripheral air spaces, emphysematous zones, large air spaces in the
peripheral lung, and diffuse interstitial pneumonia. Similar gross
appearances of the lungs, e.g., hemorrhagic areas, have been reported
in humans following exposure to large concentrations of NO2 (Parks
1974). Other studies have shown that NO2 exposure increases protein
content and glucose metabolism in lung tissue. Cytosolic enzyme
activities such as glucose-6-phosphate dehydrogenase, glutathione
peroxidase and reductase, and disulfite reductase are also increased in
the lung. Experiments with rats exposed to 5, 7, or 10 ppm NO2
resulted in an increase in glucose consumption via the Hexose
69
Monophosphate Shunt, increasing production of lactate and pyruvate
(Mustafa et al. 1980).
Haley’s (1980) review of the physiological effects of AN inhalation
mentions that subcutaneous administration of AN in rabbits produced
diuresis, albuminuria, and glycosuria. He also reports that after AN
inhalation, glucose and lactic acid were detected in the urine. Thus,
exposure of mice to AN could have produced the same physiological
efects as NO2 exposure and, as a consequence, the exposed group
may have had an increased lipid peroxidation and glucose consumption
followed by increased excretion of glucose compared to the control
group, leading to lower body weight and lower weight gain. lt has
also been shown that these aikyl compounds can be nitrosating
(Osterloh and Goldfield 1984), thus posing a further hazard in their
potential carcinogenic effect. Although this effect has been shown in
vitro, there are currently no data on the amounts of nitrosamines
formed in vivo in humans. However, this danger should not be
ignored.
The work presented here disagrees with the findings reported by the
Centers for Disease Control (1983), which attributes differences to
the methodologies and substances used. CDC researchers exposed
their animals to vapors of IBN for 18 weeks; whereas the present
study administered AN intranasally for 21 weeks. lt is possible that
immunotoxic effects do not reveal themselves until certain
concentrations and exposure times have elapsed. Prior to the start
of our experiments, we exposed a few animals to 5, 10, and 15 µI of
AN. Those animals receiving 10 and 15 µl of AN for the first time
died immediately after exposure. Animals receiving 5 µl became very
ill and one died within 24 hours; the rest survived. For this reason,
we administered AN in small doses and slowly increased the amount
given. Eventually the animals were able to tolerate 10 µl  of AN
without any noticeable ill effects. Apparently animals do develop
tolerance to AN; however, felt that a maximum of 10 µl /day was a
reasonable sublethal dose.
Several reports in the medical literature suggest that AN might be an
inducer of Kaposi’s sarwma (Jorgensen and Lawesson 1982, Goedert et
al. 1982; Digiovana and Safai 1981; Haverkos et al. 1985) other
researchers refute the argument (Durack 1981; Jaffe et al. 1988).
More recent in vitro studies using IBN show this agent to be
immunotoxic (Hersh and Reuben 1983; Mayer 1984; Newell et al. 1984)
at very low concentrations. In addition, CDC’s latest epidemiological
report demonstrates a possible link between nitrites (poppers) and
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Kaposi’s sarcoma. A survey of 87 AIDS victims found that
significantly more sufferers of Kaposi’s sarwma reported heavy use of
poppers than did sufferers of Pneumocystic carinii pneumonia.
CONCLUSION
The studies presented here show that chronic inhalation of AN can
lead to a decrease in helper cells, thus altering the T-cell H/S ratio,
which is the same phenomenon that occurs in AIDS victims. This
suggests a link between AN inhalation and cellular immunity
depression.
In view of the results reported here, there is an urgent need to
confirm these findings and to perform microscopic anatomy studies of
lung tissue and possibly other organs to elucidate the pathologic
effect of AN. In addition, challenge studies with pathogenic and
nonpathogenic organisms should be conducted after long-term
exposure, along with humoral immunity studies.
Since the termination of this study, various reports in the literature
have shown that a more appropriate reagent for measuring helper T-
cell populations would be the L3T4 antigen (Swain et al. 1984). For
this reason we recommend that these results be confirmed using the
more recently discovered antigens. We further recommend that
persons prone to using alkyl nitrites should consider the possible
adverse health effects that could emanate from inhaling these
substances and thus should refrain from using them.
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Effects of Nitrites on the Immune
System of Humans
Elizabeth M. Dax, James E. Nagel,
W. Robert Lange, William H. Adler, and
Jerome H. Jaffe
INTRODUCTlON
Kaposi’s sarcoma (KS) is a disease manifestation of unexpectedly high
occurrence in homosexual men with acquired immunodeficiency
syndrome (AIDS) and has been recognized as such since 1981 (Centers
for Disease Control 1981). In other groups of people with AIDS, the
occurrence of KS is less frequent (3 to 4 percent vs. approximately
14 percent in the homosexual group) (Centers for Disease Control
1986). Epidemiological evidence indicates that factors associated with
the presence of KS in patients with AIDS include sexual activity
(Jaffe et al. 1983). drug usage, particularly the use of volatile nitrites
(Haverkos et al. 1985), and a history of sexually transmitted diseases
and possibly their therapies (Marmor et al. 1982). The association
between nitrite abuse and the development of KS has been
demonstrated in some studies (Marmor et al. 1982; Haverkos et al.
1985) but has not been supported in the studies of Polk et al. (1987).
In some samples the use of volatile nitrites by homosexual men
approaches 100 percent (Israelstam et al. 1978; Marmor et al. 1982).
Conversely, it has been reported that few heterosexual patients with
AIDS use nitrites (Guinan et al. 1984). Thus, the question arises
whether the nitrites are surrogate markers of other factors involved
in the development of KS, or whether they, themselves, are cofactors
in the development of this disease in AIDS patients. It has been
suggested that nitrites may be involved in the development of KS by
intrinsic immunosuppressive properties.
There are several possible explanations of the nitrites’ ability to act
as cofactors in the development of KS in AIDS patients. Most
important, there is evidence that nitrites may compromise the immune
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system. Goedert et al. (1982) found low helper:suppressor T-
lymphocyte ratios in eight volunteer, homosexual men who regularly
used nitrite compared with seven volunteers who were not regular
users. The altered T-lymphocyte ratios were due to decreases in
helper cells as well as increases in suppressor cells. Cytomegalovirus
(CMV) antibody titers were high in 14 of the 15 volunteers but were
not related to either nitrite abuse or T-cell abnormalities. The
authors concluded that “nitrites may be immunosuppressive in the
setting of repeated viral antigenic stimulation, and may contribute to
the high frequency of KS and opportunistic infections in homosexual
men” (Goedert et al. 1982, p. 412). In another study, Hersh et al.
(1963) examined the effects of nitrites administered in vitro on
parameters of lymphocyte function. A dose response inhibition of in
vitro blastogenic response to mitogens, natural killer cell activity,
antibody-mediated cellular toxicity, and adherence and transformation
of monocytes to macrophages was observed. Again, the authors
suggested that nitrites have an immunosuppressive effect on mono-
nuclear leucocyte function. Animal studies support the proposal that
nitrites are immunosuppressive (Lewis and Ortiz, this volume). To
date, immunological function following inhalation of nitrites has not
Been reported. This paper summarizes preliminary results of such a
study.
MATERIALS AND METHODS
Eight HIV-negative male volunteers gave informed consent to
participate in this study. They were in residence on the Addiction
Research Center ward. During the first week of the study two
Baseline immunologicol test batteries were run. Over 4 days of the
second week, each volunteer participated in 13 inhalation sessions
(0.18,0.3, and 0.46 ml amyl nitrite each three times, and four placebo
doses). The placebo, banana oil, was included in each inhalation
session with or wlthout amyl nitrite. The drugs were inhaled from a
4-liter flask connected to a collapsible breathing bag which contained
a known volume of air. Another inflow valve was opened when the
bag was fully collapsed in order to ensure full inhalation of the
nitrite dose. Blood was drawn for immunological tests immediately
following the last inhalation session, then at 24 hours, 96 hours, and
7 days.
Tests of immune status included white cell counts, absolute
lymphocyte numbers, lymphocyte subset representation, in vitro
lymphocyte responses to the mitogens Phytohemaglutanin (PHA),
Concanavalin A (ConA) and pokeweed mitogen (PWM), natural killer
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cell activity, and in vitro polyclonal induction of immunoglobulin G
(IgG) and immunoglobulin M (IgM) synthesis.
The determination of lymphocyte subsets utilized monoclonal
antibodies against membrane markers. The OKT series of antibodies
were obtained from Ortho Diagnostics, and the Leu series were
obtained from Becton Dickinson. The stained cell preparations were
analyzed using an Ortho 50H Cytofluorograph (Nagel et al. 1981 b).
The in vitro responses to mitogens were determined by culturing 5 x
104 lymphocytes in 0.2 ml volumes in indivldual well microculture
plates. The cells were grown in RPMI 1640 (Grand Island, NY)
supplemented with 10 percent fetal calf serum with 100 ug penicillin
and 100 ug streptomycin per ml. Cultures were maintained for
72 hours with 1 Ci 32' H-Trd present for the last 18 hours. Results
are presented as the mean cpm for three replicative samples. Natural
killer cell activity was determined using Cr51 labeled K562 tumor
cells as targets. Peripheral blood lymphocytes were diluted to
provide effector to target (E:T) ratios of 100:1 to 0.78:1. The
resulting cytotoxicity curves were examined for linearity. Results are
expressed as specific cytotoxicity for the 12.51 E:T ratio previously
described (Nagel et al. 1981 c). In vitro immunoglobulin production
was analyzed using cultures of peripheral blood lymphocytes in the
complete media described above. PWM was used as a polyclonal
activator of immunoglobulin production (Nagel et al. 1981 a). The
quantitation of IgM and IgG content in culture supermates was
accomplished using an ELISA technique with specific enzyme-linked
anti-immunoglobulin reagents. Results are expressed as the peak
amount of IgM and IgG in different cultures stimulated with varying
doses of PWM.
RESULTS
The T-lymphocyte line associated with cell-mediated immunity carry
surface antigens recognized by the CD3, CD4, and CD8 antibodies for
the immature, T4 helper, and T8 suppressor cells, respectively. The
B-cell line lymphocytes, which produce immunoglobulins, are identified
with the Leu-12 antibody.
The representation of T-lymphocyte subsets as the percentage of total
lymphocytes was unchanged after amyl nitrite inhalation. Therefore,
there were only minor variations in the lymphocyte helper/suppressor
ratio (T4/T8) following inhalation of amyl nitrite. However, the ab
solute number of peripheral blood lymphocytes decreased significantly
following the inhalation protocol, then returned to baseline levels
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after 24 hours, and increased over baseline levels at day 7. The
absolute numbers of CD3+ and CD8+ lymphocytes were significantly
decreased immediately following inhalation. Natural killer ceils (leu-
7+11) doubled in percentage representation between baseline levels
and the second day post-inhalation while the level of natural killer
cell activity showed an initial significant decrease, then returned to
baseline levels by day 4 post-inhalation. The percentage
representation of leu-12+B -lymphocyte showed an increase from 12.6
to 17.4 percent between day 4 and day 7, which corresponded to an
increase in the in vitro PWM-induced immunoglobulin synthesis. The
response to the T cell mitogens Con A and PHA was significantly
elevated on day 7 following exposure to nitrite. The results showed
a nitrite-induced lymphopenia resulting from relatively short exposure.
Further, a nonspecific, perhaps compensatory, immunostimulation
following exposure to amyl nitrite was compatible with the suggestion
that the nitrites may aggravate symptoms by enhancing HIV
replication. The nonspecific stimulation could mask or interfere with
specific immune responses to pathogens.
CONCLUSIONS
The results showed that exposure to amyl nitrite can induce changes
in immune function even after short exposure to moderate doses.
Several tests of immune function showed an “overshoot” over basal
activity at 7 days following nitrite inhalation after an initial
immunosuppression. A possible interpretation of the results would be
that the nitrites cause a cycling of immune activity between
suppressed and nonspecific stimulated levels. This situation might
result in a period of ‘immunosuppression followed by a proliferative
period in which virus-containing cells propagate in the presence of a
nondirected immunoresponse. In the community, nitrites are often
used in an episodic manner, which may facilitate such cyclic changes.
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Deliberate Inhalation of Isobutyl
Nitrite During Adolescence:
A Descriptive Study
Richard H. Schwartz
INTRODUCTION
In the past 10 years, isobutyl nitrite has become popular as a means
of getting “high” among heterosexual adolescents, particulariy those
who abuse other “gateway” drugs. Several surveys of adolescents and
young adults reflect butyl nitrite use in the United States. In 1966
approximately 9 percent of 3,000 American high school seniors
surveyed by a standardized indepth questionnaire on drug use patterns
stated that they had deliberately inhaled volatile nitrites at least one
time in order to self-intoxicate (“get high”) (Johnston et al. 1967).
In the same study, 1.6 percent of the survey respondents had used
nitrite inhalants within the previous 30-day period, and 0.5 percent of
the respondents used the drug daily. Annual use of isobutyl nitrite
increased from the previous 3-year period. In 1983, 3.6 percent of
high school seniors inhaled isobutyl nitrite, while 4.7 percent did so
in 1966. The National Institute on Drug Abuse (NIDA) Household
Survey of children 12 to 17 years old is in dose accord with the
high school senior survey: 9 percent of the 12- to 17-year-old
respondents admitted to lifetime use of isobutyl nitrite, and 4 percent
were current users (National Institute on Drug Abuse 1986). In New
York State, 6 percent of 1.3 million 7th to 12th grade students
surveyed inhaled isobutyl nitrite during the 1983 school year, 3
percent were current users, and 1 percent, or 9,000 students, did so
at least 10 times in the 30-day period prior to the large statewide
survey on drug use frequencies and patterns (New York State Division
of Substance Abuse Services 1984).
lsobutyl nitrite, a licit chemical sold allegedly as a room odorizer in
some pornography, record, and tape shops, and by mail order from
magazine advertisements, is a popular drug of abuse among American
teenagers. The drug is chemically similar to amyl nitrite, an inhaled
volatile liquid that is used in the emergency treatment of cyanide
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poisoning. lt has a rather unpleasant chemical odor, which is said to
resemble sweaty socks or the smell of a men’s locker room.
lsobutyl nitrite is sold legally under various trade names. Among the
more common are Rush, Locker Room, Bullet, Quick Silver, Thrust,
Lightning Bolt, and Hardware, many of which have sexual
connotations. lt is estimated that 12 million bottles of the products
were sold between 1978 and 1983 (Freezer 1978). The most common
sources of these products are underground outlets such as “head
shops” and pornography shops.
Labels on some vials of isobutyl nitrite bear clear printed warnings to
“avoid inhalation” of the vapors One label even reads “Danger:
Excessive Use May Cause Euphoria.”
The immediate effect of inhaling isobutyl nitrite is a sensation of
warmth and a lightheaded feeling that adolescents call a “head rush.”
This phenomenon, which is due to profound vasodilation, lasts only a
few minutes. Common physiological effects include pounding
headaches, dizziness, blurred vision, and pressure in the eyes.
Postural hypotension leading to loss of consciousness can easily occur
if the drug is inhaled while standing. Prolonged exposure to the
vapors can cause irritation to the eyes and the tracheobronchial tree
(Covalla et al. 1981). lf isobutyl nitrite is accidentally spilled around
the nose during inhalation, it can cause dermatitis and pronounced
yellow crusting on the upper lip or in the nasal passages (Fisher et
al. 1981). In some individuals, the consequences of using this product
may be much more severe: some methemoglobin-reductase enzyme-
deficient persons develop severe methemoglobinemia or Heinz body
hemolytic anemia after sniffing isobutyl nitrite (Horne et al. 1979;
Bogart et al. 1988; Dixon et al. 1981).
PATIENT POPULATION AND STUDY DESIGN
We recently had an opportunity to evaluate the extent and
consequences of the use of isobutyl nitrite among a select group of
youth. The 173 persons in our study were patients in a drug
treatment facility which is a long-term therapeutic community for
chemically dependent adolescents. These young people were
predominantly white and middle class. The vast majority had a
diagnosis of primary dependency or abuse of cannabis or alcohol.
Most had also abused a wide array of mood-altering drugs including
inhalant drugs, LSD, PCP, and cocaine.
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The data in our study were gathered from a 21-item questionnaire
about isobutyl nitrite use, answered by patients present at the
treatment facility on a single day.
After a general announcement about the purposes of the study and
the guidelines for voluntary participation, the questionnaire was given
to individuals attending a large group therapy session consisting of
approximately 200 patients. They were informed that the purpose was
for medical research only. Participation was entirely voluntary; there
were no rewards or consequences based on a client’s decision of
whether or not to participate. The confidential questionnaire had
been approved by the program director and the professional treatment
staff.
RESULTS
Seventy-four (43 percent) of the 173 respondents (85 percent were
male, 35 percent were female) to the survey reported that they had
abused isobutyl nitrite for the purpose of self-intoxication; however,
52 (30 percent) had used it less than 10 times each. An additional 16
(9 percent) had used it between 10 and 99 times. Six (3 percent)
estimated that they had inhaled isobutyl nitrite on more than 100
occasions. Of the 22 individuals who had inhaled the vapors more
than 10 times, 19 were male.
The 22 clients (mean age 17 years), who inhaled isobutyl nitrite at
least 10 times had almost all been introduced to the drug by a close
friend. The substance was almost always used by inhalation directly
from the vial.
lsobutyl nitrite had been inhaled in solitude on at least one occasion
by 71 percent of the 22 frequent users, a particularly dangerous
practice if the user was standing or driving a car at the time because
of the cardiovascular effects. Relatively few (17 percent) used the
drug before heterosexual intercourse and none admitted to use before
anal intercourse. The average cost of a 12 ml bottle of isobutyl
nitrite (Rush) was reported at $5 to $6. Most of the young people
obtained the drug from a friend or purchased it from “head shops”
(33 percent), record stores (17 percent), pornography shops (11
percent), or mail-order catalogues (6 percent).
Nearly half the users described their experiences with isobutyl nitrite
as “unpleasant” because of universal symptoms of lightheadedness and
dizziness, as well as rapid heartbeat, blurred vision, facial flushing,
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and headache. Thirty-four percent reported severe pulsatile
headache, 17 percent reported burning in the nose, and 11 percent
reported nausea immediately after inhalation of the drug. Probably
because of the unpleasant odor and physiological effects of the
volatile vasodilator drug, the euphoric effect (“high”) was described
as only “fair to good” by 56 percent of the respondents.
CONCLUSION
We believe that the results reported may reflect the extent and side
effects of the use of isobutyl nitrite among adolescents in drug
treatment programs. Being honest and open about their drug
problems was an integral part of the treatment program that these
individuals were undergoing. Conclusions from three published studies
support the validity of self-reporting of drug use by adolescents
(Smart and Jarvis 1981; Needle et al. 1983; Benson and Holmberg
1985).
The widespread and apparently increasing use of isobutyl nitrite as a
euphoric agent by teenagers warrants consideration of banning the
sale of isobutyl nitrite.
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Nitrite Inhalants:
Contemporary Patterns of Abuse
W. Robert Lange, Elizabeth M. Dax
Charles A. Heartzen, Frederick R. Snyder,
and Jerome H.Jaffe
INTRODUCTION
Amyl nitrite has been used medically since 1867 in the management of
coronary insufficiency (Brunton 1867), and even though the agent is
used infrequently in clinical therapeutics at this time, it does have a
contemporary role in diagnostic cardiology and diagnostic radiology
and in the management of cyanide poisoning. The history of butyl
and isobutyl nitrites (collectively referred to hereafter as butyl
nitrite) is more recent. Whereas amyl nitrite is a prescription drug,
butyl nitrite is marketed as a room odorizer. Even though it has no
clinical or practical utility, it is widely available and has been
endowed with a certain mystique.
Beginning in the late 1960s and into the early 1970s, reports began to
surface that nitrite inhalants were being abused by both sexes in an
attempt to augment the physical pleasure of sexual intercourse
(Everett 1972). Soon nitrite inhalants became known as “poppers” (an
onomatopoetic street name derived from the sound of breaking an
amyl nitrite pearl), and abuse patterns took two distinct courses. As
a street drug, poppers were frequently used on social occasions, often
in discotheques, to promote a sense of abandon while dancing, to
expand creativity, to stimulate music appreciation, and to enhance
meditation (Sigell et al. 1978). Others used them on a more general
basis for a euphorigenic rush, an altered state of consciousness, and
even as a stimulant (Nickerson et al. 1979). There is no scientific
evidence, however, that any of these effects are associated with the
use of nitrite inhalants.
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A more widespread pattern of use was associated with overt sexual
activities. Purported attributes included prolongation of penile erec-
tion and relaxation of rectal smooth muscle and anal sphincter tone,
thus facilitating intromission (Labataille 1975). Other alleged drug
effects included heightened libido, i.e., an aphrodisiac, prevention of
premature ejaculation, increased volume of ejaculate, and promotion
of a generally intensified or prolonged sexual experience (Israelstam
et al. 1978).
Although awareness of adverse health effects of nitrite abuse was
raised in the 1970s (Louria 1976), real concerns surfaced with the
advent of the acquired immunodeficiency syndrome (AIDS) epidemic,
and the growing body of data suggesting that the volatile nitrites
may influence immunomoduiation or otherwise be a cofactor in the
pathogenesis of human immunodeficiency virus (HIV) infection and
certain AIDS-related syndromes. For example, of the first five homo-
sexual men with AIDS reported to the Centers for Disease Control,
all had used nitrite inhalants, but only one had abused intravenous
drugs and only two were reported to be promiscuous (Centers for
Disease Control 1981).
Contemporary patterns of abuse of nitrite inhalants are not clearly
delineated. On one hand, a readily available drug with the reputation
of being an aphrodisiac would appear to have appreciable abuse
liability. On the other, the close association to and growing concern
over AIDS might be expected to alter patterns of abuse. This study
was a descriptive survey of two populations with a high probability of
using nitrite inhalants.
METHODS
Two distinct high-risk populations were surveyed: predominantly
heterosexual substance abusers in six regions of the United States
and homosexual men in Baltimore.
Substance Abusers
Substance abusers were surveyed in Baltimore, MD, during two sepa-
rate time frames: 1981 through 1984 (n=365) and February through
October 1986 (n=246). in addition, substance abusers in five other
regions of the United States were queried about nitrite abuse pat-
terns as part of a national HIV seroprevalence survey conducted
between September 1986 and February 1987. The following regions
were surveyed: New York City (n=267); Tampa, FL (n=59);
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San Antonio, TX (n=102); Denver, CO (n=99); and Los Angeles, CA
(n-409). The Baltimore participants during both time periods were
comprised of both volunteers for National Institute on Drug Abuse-
Addiction Research Center (NIDA-ARC) research studies as well as
clients in treatment for substance abuse disorders. The former
tended to be recreational drug users not physically dependent on any
substance at the time of their participation; the latter had heavier
drug use histories. The subjects in the five locations other than
Baltimore were all individuals recently enrolled in a drug treatment
program.
Male Homosexuals
Between April and August 1966, a sample of 80 male homosexuals was
studied. Of these, 20 were interviewed while participating in the
activities of a homosexual support group, and 60 were interviewed in
gay bars in Baltimore, MD, and Washington, DC. They were queried
specifically in regard to their current and past use of both amyl and
butyl nitrites, including methods and reasons for using these drugs as
well as associated drug effects and side effects.
For the purpose of this investigation, current use was defined as use
at any time during the 6 months prior to the survey. To assess
possible differences between nitrite inhalant users and nonusers, the
data were analyzed by either of two methods. Variables measured on
an interval scale were subjected to independent samples r-tests,
whereas categoricai variables were analyzed using the chi-square
statistic.
RESULTS
Substance Abusers
Table 1 describes the Baltimore data for the two time frames. Among
recreational users (NIDA-ARC clients), the prevalence rate of nitrite
use during the preceding 6 months was 11 percent for both periods.
The participants with the heavier drug use patterns (clients in
treatment) also had a higher frequency of nitrite use, with the
current prevalence rate being 22 percent. Nitrite inhalant use was
more common in whites than in members of minority groups (x2=6.80,
p<0.05). The sexual orientation of the earlier samples is not known,
but 7 percent of both 1986 samples admitted to a history of
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TABLE 1. Prevalence of nitrite use in Baltimore substance abusers
Prevalence
Dates Mean Age White Male of Use
Sample Studied No. (Years) (Percent) (Percent) (Percent)
Early 1980s
ARC Volunteers 1981-84 203 3 2 ± 6 5 6 90 11
Clients in
Treatment 1982-84 162 3 5 ± 9 5 4 66 17
1986
ARC Volunteers 1986 6 3 3 0 ± 7 40 90 11
Clients in
Treatment 1986 183 3 2 ± 6 4 4 7 8 2 2
homosexuality, and there was no statistically significant association
between homosexual behavior and nitrite use in these groups.
ARC subjects were asked when they first began using nitrites in re-
lation to other substances of potential abuse, and these results are
depicted in table 2. The inhalable nitrites tend to be a drug class
whose use is initiated much later in life, with the mean age of first
use at 25.6 years. This compares to an age of 14.6 years for glue,
the other principal inhalant of abuse.
TABLE 2. Age of first use for substances of abuse for Baltimore
ARC volunteers
Substance Mean Age ± SD
Alcohol 13.9 ± 3.6
Glue 14.6 ± 3.2
Benzedrine/Speed 17.2 ± 3.1
Marijuana 17.6 ± 5.5
Heroin 18.5 ± 3.5
Cocaine 20.4 ± 4.4
Nitrites 25.6 ± 7.8
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Table 3 shows the geographic differences in nitrite abuse patterns.
Among abusers in treatment, use of nitrite inhalants ranged from a
high prevalence of 40 percent in Tampa to a low of 7 percent in the
New York City area (Brooklyn and Harlem). In all locations,
experience with amyl nitrite was reported more frequently than
experience with butyl nitrite.
TABLE 3. Proportion of exclusively heterosexual substance abusers
in treatment reporting nitrite inhalants, by residence
Number Queried
Exclusively EH Reporting
EH Reporting Nitrite Use
City or Region Total
Heterosexual
(EH) Nitrite Use (Percent)
Tampa 5 9 53 21 40
Denver 99 90 34 38
San Antonio 102 93 28 30
Baltimore 182 172 39 23
Los Angeles 409 397 55 14
New York city 267 241 16 7
Total 1,118 1,046 193 18
Among substance abusers, nitrite use was reported more frequently
among whites than blacks or Hispanics, and more frequently among
men than women. Thirty percent (142/475) of ,whites reported nitrite
use compared with 13 percent (31/246) of blacks and 10 percent
(35/350) of Hispanics. The highest rates of nitrite use for all six
regions were reported by whites. Twenty-one percent (159/743) of
men reported nitrite use compared to 16 percent (57/366) of women.
Within each region, men reported nitrite use more frequently than
women except in San Antonio. There, 14 of 30 women (47 percent)
and 12 of 72 men (29 percent) reported nitrite use.
Since these data were collected as part of an HIV antibody survey,
the data were analyzed to ascertain whether there were differences
in nitrite use on the basis of HIV seropositivity. Among substance
abusers in Baltimore, there was a significant association between
nitrite inhalant use and HIV seronegativity (X 2=121.6, p<0.001), and
this was felt to be secondary to the ethnicity of the sample: HIV
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seropositivity was independently associated with blacks, whereas
nitrite use was independently associated with whites. In New York,
there was a tendency for an association between nitrite use and sero-
positivity, and in Denver, there was a distinct association. However,
among the five HIV positives in Denver, three admitted to being
homosexual, and this likely confounds the data in an area with few
HIV-seropositives.
Male Homosexuals
The mean age of the homosexual sample was 30.0 years (range 18 to
56 years). The component enrolled in the support group tended to be
older (mean age 39.5 years, range 23 to 56 years) than those
recruited in gay bars. Fity-five (89 percent) admitted to ever
having used nitrite inhalants, and there were no demographic differ-
ences between users and nonusers. The mean age of first use among
the homosexuals interviewed was 22.2 years (range 18 to 42 years),
and the mean age of peak use was 25.4 years (range 17 to 45 years).
Of those who had used poppers, 43 (78 percent) reported use of only
amyl nitrite, and the remaining 12 (22 percent) had used both amyl
and butyl. Among those using both, there was a preference for amyl
nitrite, which was regarded as being more potent and less associated
with side effects. No homosexual subject in our sample admitted to
having used only butyl nitrite.
Patterns of nitrite use were assessed for the homosexual men sur-
veyed in Baltimore. Only 13 users (23 percent) reported having used
nitrite inhalants at times other than during sexual activity, and this
was primarily while dancing. Among the various sexual behaviors, use
was most often associated with masturbation (64 percent). Twenty-
six (47 percent) had used nitrite inhalants concomitantly with one or
more other drugs, with concomitant marijuana being the most
frequent (96 percent).
Despite the propensity for using nitrites during overt sexual activity,
the predominant reason given by the homosexual group for using the
substance was to get high, rather than for any anticipated physiologic
effect. Twenty-five (45 percent) reported some side effect associated
with nitrite use, the most common being headache. Three partici-
pants related that nitrite use Caused them to lose their erections, and
none credited the drug with facilitating erection, heightening libido,
or enhancing sexual enjoyment.
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Homosexuai subjects reported that the duration of the subjective
effects of nitrite inhalation was brief. The modal duration was 1
minute, with a range of 4 seconds to 15 minutes. The reported modal
frequency of we was once weekly, and the modal intensity of peak
use was four times per week. The style or technique of use was
correlated with the intensity of use, with heavy or current users
tending to inhale more deeply. They also reported a longer retention
of inhalation than did light users. The time interval since most
recent use ranged from 1 to 156 months, with a mean of 25.2 months,
and the mean period since peak use was 4.1 years (range 1 to 11
years). From the data obtained during this survey, it appears that
the use of nitrite inhalants within the gay community has decreased
appreciably in recent years. Health-related concerns were the most
frequently cited reasons for the discontinuance of the substance.
DISCUSSION
Ongoing surveillance in Baltimore afforded the opportunity to monitor
changing patterns of nitrite inhalant use among substance abusers.
Over the period since 1981 (a time which predates the AIDS epidemic)
through 1996, there appears to have been no change in the patterns
of nitrite use by substance abusers. Consistently, 11 percent of
recreational abusers participating in NIDA-ARC research protocols
have reported recent use of nitrite inhalants, as have approximately
20 percent of heavier drug users enrolling in treatment. Although it
is difficult  to rule out homosexual behavior among male substance
abusers in the study, the use of nitrites by female substance abusers
suggests that male homosexuals are not the only users of nitrites.
Even though some evidence is emerging suggesting that parenteral
drug abusers are attempting to procure new needles when they are
available (Des Jarlais et al. 1985), there is still a basic recalcitrance
to modify their drug use in the face of the risk of overdose death,
or their needle-sharing behavior in the face of the AIDS epidemic.
Consequently, there is probably little reason to anticipate that this
high-risk group will modify its use of nitrites out of concern for the
effects of these substances on the immune system.
There appear to be ethnic as well as geographic variations in nitrite
abuse, and in some of the locations studied, these factors may
confound each other. For example, Denver and San Antonio had the
highest frequencies of use of poppers, and the proportions of these
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samples which were white were 60 percent and 62 percent, re-
spectively. New York City had the lowest frequency Of use, and that
sample was only 18 percent white.
Within populations that have, a propensity to misuse a wide spectrum
of drugs, nitrites appear to be substances whose abuse begins
relatively late in life. This may reflect either a delayed availability
or a delayed popularity of nitrites. Butyl nitrites were not generally
available before 1970; therefore, they were not available during
teenage years for men and wormen currently in their thirties and for-
ties. Whereas the prevalence of nitrite inhalant use among substance
abusers has remained constant in addition to being initiated late,
other inhalant use such as glue sniffing has classically been a
phenomenon Of young abusers; and, baaed on ongoing surveillance by
the ARC, its abuse in the Baltimore area appears to be waning
appreciably.
The natural history of addiction included what has been referred to
as the “maturing-out phase” (Winick 1972). For a variety Of reasons,
many long-term, hardcore addicts either become abstinent or manifest
marked changes in their drug use patterns beginning in their late
twenties and continuing through their thirties. Many will abuse
alcohol more heavily during this period. The late use Of nitrites
suggests that these substances may, in sime drug users, be associated
with this process.
Within the homosexual population surveyed in the Baltimore-
Washington, DC, area, the current  level of nitrite use (21 percent) is
the same as that observed in heavy drug users in the same locate (22
percent). The observation that nitrite use in the gay community is
waning is encouraging; however, it is of concern that many
homosexual men who continue to use nitrites do so for the
euphorigenic properties, and will often use poppers with other sub
stances of abuse, notably marijuana. A has been observed that
homosexual men who use recreational drugs are significantly more
likely to engage in high-risk sexual practices capable Of transmitting
HIV infection than are those who do not (Polk, unpublished data).
That both substance abusers and homosexual men use nitrite inhalants
primarily to get high, and that both appear to have much more
experience with amyl nitrite rather than the butyl derivative, were
unexpected findings.
We conclude that heterosexual drug abusers in the Baltimore area do
not appear to have modified their nitrite use appreciably in recent
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years. however, data from this sample, which admittedly may not be
representative of the overall homosexual community, would suggest
that homosexual males probably have decreased their use of nitrite
inhalants. This appears to be a result of a greater awareness of
AIDS risk in this population, and a consequent trend to modify their
high-risk behavior.
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Epidemiologic Studies-Kaposi’s
Sarcoma Vs. Opportunistic
Infections Among Homosexual Men
With AIDS
Harry W. Haverkos
INTRODUCTION
Kaposi’s sarcoma (KS) is an important manifestation of AIDS. It is
the most common cancer reported among AIDS patients and its
occurrence among gay men in New York and California was one of
the earliest harbingers of the AIDS pandemic (Centers for Disease
Control 1991).
KS associated with AIDS is unique both clinically and epidemio-
logically. Unlike “classical” (or non-AIDS-related) KS among elderly
men, or “endemic” KS in some parts of Africa, KS in patients at risk
for AIDS is associated with human immunodeficiency virus (HlV)
infection and cellular immune impairment (Biggar et al. 1984; Stahl et
al. 1982). Furthermore, KS occurs much more commonly among gay
men than among non-gay AIDS patients and is the only AIDS-related
illness in which the proportion of cases has declined (Haverkos et al.
1985; Haverkos 1987b).
Nitrite inhalants were investigated as a possible cause of AIDS early
in the epidemic, partly because of the preponderance of homosexual
men who used nitrites among the early patients with AIDS. During
pilot testing of questionnaires in 1981, Centers for Disease Control
(CDC) investigators found that nitrites were used by nearly all
homosexual men with AIDS. In addition, a 1981 survey of 420 men
attending sexually transmitted diseases clinics showed that homo-
sexual men reported use of nitrites far more frequently than did
heterosexual men, and that the amount of use directly correlated with
the number of different sexual partners (Centers for Disease Control
1982). In 1982, Marmor and colleagues repotted significant associa-
tions between use of amyl nitrite and sexual activity, and the
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development of AIDS (all 20 patients in the study had KS) among
homosexual men (Marmor et al. 1982).
On the other hand, when Marmor et al. reanalyzed their data
incorporating other factors and using multivariate analysis, they found
that still other variables, including frequency of receptive anal
intercourse and antibody titers to cytomegalovirus appeared to
differentiate patients with AIDS from controls (Marmor 1984; Marmor
et al. 1994). Although AIDS patients used greater quantities of
nitrites than did controls in the initial CDC study, Jaffe showed that
nitrite inhalant use did not appear to be important in distinguishing
patients with AIDS from controls. Measures of sexual activity were
the best markers for AIDS in that study (Jaffe et al. 1993). In
addition, studies conducted by that National Institute for Occupational
Safety and Health (NIOSH) for the CDC showed no immunotoxic
reactions in mice exposed to isobutyl nitrite vapors (Lewis et al.
1985).
This paper reviews six epidemiologic studies conducted among gay
men with AIDS to examine the role of nitrite inhalants, not as a
cause of AIDS, but as a cofactor in the development of KS as a
major manifestation of AIDS. Aspects of each study reviewed
include: Basic study design, wording of the questionnaire regarding
nitrite inhalant use (kindly provided by each of the investigators),
and published results comparing nitrite inhalant use of KS patients
compared wlth those who developed opportunistic infections and not
KS. All six studies included questions about sociodermographic
variables, medical history, use of drugs, and sexual history. Patients
were invited to provide Mood and/or other specimens for laboratory
analysis. More details about the six studies are available in the
references.
REANALAYSIS OF CDC STUDIES
Basic Design: Eighty-seven gay men with AIDS (47 with KS, 20 with
Pneumocysts carinii pneumonia (PCP), and 20 with both diseases) had
participated in 3 different studies in 1981 and 1982 conducted by CDC
in large metropolitan  areas. Patients were interviewed by CDC
personnel. HIV testing was not performed.
Questionnaire: There were 10 questions about nitrite inhalant use on
the questionnaires. Patients were asked if they had ever used
inhalant sexual stimulants or “poppers” prior to the onset of illness.
If patients responded “yes” to the first question, they were asked to
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give the calendar year they first used them, the last year they used
them, how many months during that time period they used them, how
many days per average month of use, and the number of “sniffs” per
average day (or night) of use. Questions about the location of use
(bathhouses, discos, Other) and types of nitrites (ampules, labeled
bottles, unlabeled bottles) were asked. Respondents were asked to
identify specific brand names of labeled bottles used and to identify
Where they purchased unlabeled bottles of nitrites.
Results: Eighty-four of the 87 (97 percent) AIDS cases in the studies
reported nitrite inhalant use. The median frequency of use was 394
days. Sixty percent of KS patients and those with both diseases used
nitrites more than 394 days compared with 10 percent of PCP
patients. Compared with PCP patients, KS patients and those with
both diseases reported more sexual partners, more “recreational” drug
use, higher incomes, and higher rates of non-B hepatitis.
Multivariate analysis showed that the variable most strongly
associated with KS was the use of large quantities of nitrite inhalants
(Haverkos et al. 1985b).
MOUNT SINAI SCHOOL OF MEDECINE, NEW YORK
Basic Design: A longitudinal study of 42 homosexual men with
persistent generalized lymphadenopathy was started at Mt. Sinai
School of Medicine in 1981. Over the 4 1/2 years of the study, 12
patients (29 percent) have developed AIDS, 8 with KS. Question-
naires were self-administered.
Questionnaire: The questionnaire contained eight questions about
nitrite inhalant use and was based on the one developed by CDC.
Mt. Sinai investigators deleted questions on the brand names of
labeled bottles and place of purchase of unlabeled bottles and
changed the question about location of use in bathhouses to ask
about use during sex or at discos.
Results: All 42 participants had used nitrites. The amount of nitrite
use was statistically associated with the development of KS (Mathur-
Wagh et al. 1984; Mathur-Wagh et al. 1985).
UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO
Basic Design: An AIDS case-control study among gay men in San
Francisco started in 1993 and evolved into a longitudinal study. By
April 1986, 158 men in the initial cohort had developed AIDS, 108 had
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KS. Trained interviewers administered the questionnaires. This study
is unpublished, but was presented at the First International AIDS
Conference in Atlanta (Osmond et al. 1985) and at a National
Institute of Allergy and Infectious Diseases-sponsored meeting in
April 1986 (Haverkos 1987a).
Questionnaire: The questionnaire contained seven questions about
nitrite inhalant use: first and most recent nitrite use, number of
days or nights of use during an average month, and number of “hits”
on a typical day or night of use. lt also asked about the amount of
use in the last 30 days and last year.
Results: Patients with KS were 2.2 times more likely to report
greater than four “hits” per night than patients with opportunistic
infections reported. Patients with KS, compared to patients with
opportunistic infections, were more likely to report a large number of
sexual partners, practice analingus, use large quantities of
recreational drugs by routes other than intravenous, and receive
metronidazole therapy for intestinal parasites. Patients with
opportunistic infections were more likely to report syphilis and to use
drugs intravenously than were patients with KS. Multivariate analysis
showed that the variable most strongly associated with KS was the
use of more than four “hits” of nitrite inhalants per night of use.
NATIONAL CANCER INSTITUTE
Basic Design: Two hundred forty-five men (85 from Manhattan and
160 from Washington, DC) were prospectively followed starting in
1982. Self-administered questionnaires were given to participants at
entry and at followup visits. Nineteen have developed AIDS, 8 of
whom had KS (Goedert et al. 1986).
Questionnaire: The questionnaire contained 15 questions about nitrite
inhalants. Patients were asked if they ever used nitrite inhalants
(“poppers”), what year they first used them, and to estimate the
number of days of use during the past 30 days. The participants
were asked to complete a grid containing four questions each for
their use in 1982, 1981, and 1980. They were asked to estimate the
number of days of use in each year, the number of sniffs on a
typical day of use in that year, the types of nitrites (unlabeled brown
bottle, “snapper,” brand name) used at least twice a month during
that year, and whether nitrites were used during sex acts, at other
times, or both for each year. The questionnaire contained a listing
of examples of brand names of labeled bottles.
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Results: “Nitrite inhalant use, measured as frequency during the
previous year or intensity (number of sniffs) during the previous 6
months, was not significantly associated with AIDS, Kaposi’s sarcoma,
or Pneomocystis pneumonia (Goedert et al. 1986, p. 332).” Several
variabies were associated with the development of KS, including
receptive fellatio, frequent enemas/rectal douches, high levels of
antibody to hepatitis B antigen, and use of methaquaalone (Goedert et
al. 1986).
MULTICENTER  AIDS  COHORT
Basic Design: The Multicenter AIDS Cohort Study (MACS) is a
prospective study of homosexual men in Baltimore/Washington,
Chicago, Los Angeles, and Pittsburgh supported by the National
Institutes of Health (NIH). Four thousand nine hundred fifty-
men were enrolled in 1984 and are evaluated every 6 months.
Questionnaires are administered by trained interviewers. One
thousand eight hundred thirty-five were HIV seropositive on entry, 59
have developed AIDS (24 with KS) during a median followup of 15
months (Polk et al. 1987).
Questionnaire: The questionnaire contains eight items concerning
nitrites and concentrates on use in the previous week, 8 months, and
2 years. Emphasis is also placed on the use of nitrite inhalants
during sex in the previous 6 months and 2 years.
Results: No association between nitrite inhalant use and KS was
reported. Significant associations for KS were found for decreased
hemoglobin level, decreased T-helper lymphocyte count, and increased
immunoglobulin A levels (Polk et al. 1987).
SAN FRANCISCO HEPATITIS B COHORT STUDY—CDC 
Basic design: In 1984, followup of 6,700 homosexual men enrolled In
a 1978 hepatitis B study was initiated. Ninety-six of the men were
found to have AIDS (54 with KS) and were available for interview.
Questionnaires were administered by trained personnel (Darrow et al.
1986, Darrow et al. 1987).
Questionnaire: The questionnaire contained three questions about
nitrite inhalant use as follows: "Before your onset date for AIDS,
about how many days in an average month would you use nitrite
inhalants: 1. unlabeled bottles, 2. labeled bottles, and 3. ampules?”
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Results: No differences in nitrite use were found between disease
groups. The development of AIDS in men infected with HIV may be
related to duration of infection, older age, and repeated exposures to
HIV.
DISCUSSION
The results of epidemiologic studies concerning nitrite inhalant use
and the development of KS among homosexual men with AIDS are
inconclusive. Of the six studies reviewed in this paper, three find a
strong association between larger quantities of nitrite inhalant use
and KS, and three do not confirm the association.
The questionnaires used in the six studies vary significantly in the
amount of information sought concerning nitrite inhalant use. Studies
begun in 1981 and 1982 asked more detailed questions about nitrites
than later studies asked, possibly because nitrites were considered a
possible cause of AIDS early in the epidemic. After HIV was
discovered as the cause of AIDS, epidemiologic studies tended to
focus more on sexual activities than on nonintravenous drug use. In
addition, nitrite inhalant use among gay men may be declining since
the AIDS epidemic (Lange et al., in press). lf so, questions asked in
1985 and 1986 about nitrite use in the previous 6 months or 2 years
cannot reflect accurately the amount of nitrite use at earlier times,
and, possibly more important, nitrite use at the time of HIV
infection.
The differences in outcomes of these studies may be due to
differences in study methods. The sample s&es of the studies are
small. The largest study evaluated 150 AIDS patients, 100 with KS
(Osmond et al. 1985). The smallest study evaluated 12 patients, 8
with KS (Mathur-Wagh et al. 1984). The various patient recruitment
processes may have introduced unsuspected selection biases. Several
of the studies used self-interviews, others used trained personnel to
administer the questionnaires. Although there is no evidence to
suggest that self-interviews are less reliable than face to face
interviews, information bias must be considered in any study involving
personal items, such as sexual and drug history.
There have been several hypotheses concerning the possible
mechanism by which nitrite inhalants may promote KS in users
infected with HIV. First, nitrite inhalants may act directly on the
immune system (Goedert et al. 1982). Second, nitrosamines, among
the possible metabolites of nitrites, are carcinogenic (Jorgensen and
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Lawesson 1982). Interactions of nitrites and mouse skin lipids have
been shown to produce potentially carcinogenic substances (Mirvish et
al. 1986). Third, the vasodilatory action of nitrite inhalants may, in
some way, promote KS, a malignancy of the endothelial cells lining
blood vessels. Finally, use of nitrites may only be a marker for
another cofactor, e.g., an as-yet “unidentified” microorganism.
National Cancer Institute investigators have proposed a hepatitii A-
like organism as the KS cofactor (Weiss and Biggar 1986).
Several epidemiologic observations suggest that an infectious cofactor
is less likely than nitrites. The “unidentified” virus must be highly
associated with gay sexual activity. This would imply a sexually
transmitted and/or bloodborne agent. Clearly the KS cofactor is not
boodborne. Blood donors who develop KS have transmitted HIV
infection to recipients, but those recipients do not develop KS
(Curran et al. 1984). There is no documented evidence that the
cofactor is sexually transmitted; there is no consistent pattern of KS
transmission among clusters of homosexual men linked by sexual
contact and developing AIDS (Auerbach et al. 1984). KS has not
been reported in a female partner of a bisexual man with KS. The
strong association of KS with increased income in one study is
consistent with the argument that a drug is more likely to be the
cofactor than a sexually transmitted agent (Haverkos et al. 1985b).
RECOMMENDATIONS
More epidemiologic and laboratory studies are needed to ascertain the
role, if any, of nitrite inhalants as a cofactor in AIDS-related KS.
Investigators need to develop questions that quantitate lifetime nitrite
exposure and measure dose more accurately. (The concept of “pack-
years” to quantitate cigarette use may be a useful model.)
Questioning heterosexual AIDS patients who have KS about nitrite use
may be helpful. Study of animal models infected with retroviruses
and challenged with large quantities of nitrites before, during, and/or
after retrovirus infection would be useful. Finally, the U.S. Public
Health Service could organize a multiagency task force to resolve this
issue as was done for aspirin use and Reye’s syndrome.
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